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Resumo 
O parasita Toxoplasma gondii infecta mais de um terço da humanidade sendo a 
toxoplasmose uma ameaça permanente, uma vez que os seres humanos permanecem infectados a 
vida toda. Esta tese de doutoramento teve como objetivo enriquecer o conhecimento sobre a 
toxoplasmose em Portugal e implementar abordagens optimizadas para a propagação de T. gondii 
no laboratório de referência. 
Começámos por avaliar a seroprevalência da população portuguesa comparando três 
estudos transversais ao longo de três décadas (1979/80, 2001-2002, 2013), com especial foco nas 
mulheres em idade fértil. Observámos uma tendência decrescente da seroprevalência ao longo do 
tempo (de 47 % em 1979/80 para 22 % em 2013), aumentando esta com a idade. O cenário 
observado para as mulheres em idade fértil indica que mais de 80 % são suscetíveis à infecção 
primária encontrando-se assim em risco de contrair toxoplasmose. 
Focámo-nos também no estudo do parasita e caracterizámos geneticamente 48 estirpes 
isoladas a partir de amostras biológicas de pacientes diagnosticados no Instituto Nacional de 
Saúde (INSA), para os quais efetuámos uma avaliação retrospectiva que estimou 1,6% de novos 
casos de toxoplasmose congénita nos últimos 10 anos. Este estudo revelou variações genéticas 
nas estirpes de T. gondii causadoras de infecção, mais especificamente, a existência de uma 
proporção considerável (21 %) de estirpes recombinantes, que se acredita estarem associadas a 
fenótipos específicos. 
Finalmente, avaliámos diversas abordagens laboratoriais com o objectivo de reduzir a 
utilização do número de ratinhos sacrificados na actividade laboratorial de referência. Concluímos 
que a propagação de uma forma alternada do parasita numa uma linhagem celular e em ratinhos 
constitui um procedimento laboratorial promissor, pois, para além de reduzir o número de animais 
sacrificados em mais de 80 %, permite também que T. gondii não perca a sua virulência, mantendo 
potencialmente o seu genoma inalterado. 
Globalmente, esta tese de doutoramento não só contribuiu para o conhecimento da 
toxoplasmose em Portugal, ao nível do individuo, elucidando a tendência cronológica do estado 
imunitário da população portuguesa, bem como ao nível do parasita, identificando o perfil 
genético das estirpes de T. gondii circulantes causadoras de infecção humana e a sua virulência 
no ratinho. Finalmente, esta dissertação de doutoramento estabeleceu procedimentos que 
modificaram o modus operandi do laboratório de referência que visam uma redução significativa 
do número de ratinhos sacrificados. 
 
Palavras-chave  Toxoplasma gondii; Genotipagem; Estirpes recombinantes; Toxoplasmose 
congénita; Seroprevalencia; Vigilância laboratorial. 
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Abstract 
Toxoplasma gondii infects over a third of the world's humanity and toxoplasmosis  
constitutes a life-long threat since humans remain infected throughout life. This PhD dissertation 
aimed to enrich the knowledge on toxoplasmosis in Portugal and to implement updated 
approaches regarding T. gondii propagation in the reference laboratory.  
We started by evaluating the seroprevalence in Portugal by comparing three cross-sectional 
studies spanning three decades (1979/80, 2001-2002, 2013), with focus on childbearing women. 
Seroprevalence showed a decreasing trend over time (from 47 % in 1979/80 to 22 % in 2013) and 
increased with age. The scenario observed for childbearing women indicates that more than 80 % 
of these are susceptible to primary infection and thus to congenital toxoplasmosis.  
We also focused on the parasite and genetically characterized 48 strains isolated from 
biological samples from patients attending to the NIH, for which a retrospective evaluation 
estimated 1.6 % of new cases of congenital toxoplasmosis in the last 10 years. This study revealed 
genetic variations in T. gondii and more specifically the existence of a considerable proportion 
(21 %) of recombinant strains, which are believed to be associated with specific phenotypes. 
Finally, we evaluated laboratory approaches towards the reduction of sacrificed mice in 
toxoplasmosis reference laboratories. We observed that the alternate passaging of the parasite in 
a cell line and in mice constitutes a promising laboratory procedure as, besides the reduction of 
sacrificed mice in more than 80 %, it enabled T. gondii to retain the virulence potential while 
keeping a putative stable genome.  
Globally, this PhD dissertation not only increased the knowledge on toxoplasmosis in 
Portugal by elucidating the chronological trend of the immune status of the population and the 
general genetic profile of the T. gondii strains causing human infection, but it also modified the 
modus operandi of the reference laboratory towards the significant reduction of scarified mice.  
 
 
Keywords  Toxoplasma gondii; Genotyping; Recombinant strains; congenital toxoplasmosis; 
Seroprevelenve; Laboratory surveillance. 
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pathophysiology, transmission, clinical features, diagnosis, treatment and epidemiology of 
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Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three 
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1. General Introduction 
1.1. Toxoplasma gondii, the parasite 
1.1.1. Historical background and taxonomy 
The Toxoplasma gondii (T. gondii) is an apicomplexan protozoan parasite and one of the 
most successful parasites worldwide due to its ability to infect all warm blooded animals including 
humans. One third of the world’s human population is assumed to be infected with T. gondii 
(Louis M. Weissa; Weiss and Dubey, 2009; Innes, 2010). This ubiquitous obligate intracellular 
organism was first discovered in 1908 by Charles Nicolle and Louis Manceaux at the Pasteur 
Institute in Tunis, who found the parasite in the liver and spleen of a North African rodent, named 
gundi (Ctenodactylus gundi) and initially presumed it was a species of Leishmania. In the same 
year, Alfonso Splendore, a Brazilian scientist discovered the parasite in a rabbit (Oryctolagus 
cuniculus) and again mistakenly identified it as Leishmania (Ferguson D, 2009). However in 1909 
following experimental infection and microscopic analysis, the parasite was renamed to 
Toxoplasma gondii as described by Nicolle and Manceaux (Nicolle and Manceaux, 1909; 
Ferguson D, 2009) due to the bow shaped morphology of the extracellular stage of the parasite - 
tachyzoite; Toxo is derived from Greek for bow, plasma meaning life and gondii because its 
original host was C. gundi. In 1914 Castellani was probably the first to describe a T. gondii–like 
parasite in smears of the blood and spleen from a 14-year-old boy from Ceylon who died from a 
disease characterized by severe anemia, fever and spleenomegaly. (Louis M. Weissa; Cheng et 
al., 2015). 
In 1923, Janků observed parasitic cysts in the retina of an eleven month old child who was 
suffering from hydrocephalus (Janků, 1928). In the same year the first identified case of 
congenital toxoplasmosis was reported by Wolf and Cowen from a 3 day old child who had 
developed seizures (Wolf et al., 1939). The baby only survived for one month and following post 
mortem cerebral calcification, retinochoroiditis, and hydrocephalus were observed.  In this same 
year Sabin isolated T. gondii from two children from Cincinnati, named R.H. (initials of the 
patients name), aged 6 years old and the other named W.B.D. aged 8 years, with encephalitis 
(Sabin, 1941). This strain, designated “RH” became the laboratory prototypical Type I strain and 
since 1938 it has been passed in mice in many laboratories worldwide. In 1941, Pinkerton and 
Henderson reported atypical pneumonia on two adults who died and in whom they demonstrated 
T. gondii as the etiological agent. These were the first reports of acute toxoplasmosis in adults 
without neurological signs. In the 1950’s T. gondii parasites were discovered in enucleated eyes 
(Wilder, 1952), and this type of ocular toxoplasmosis was presumed to be a consequence of 
congenital transmission of the parasite. However, more recent studies have also described a 
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greater number of cases than expected of ocular toxoplasmosis due to postnatal acquired infection 
(Montoya and Remington, 1996; Burnett et al., 1998; Gilbert et al., 2008).  
The development of a serological test, the dye test, in 1948 by Albert Sabin and Harry 
Feldman was a major advance in the study of toxoplasmosis (Sabin and Feldman, 1948). The 
ability to identify T. gondii infections based on this serological method allowed epidemiological 
studies on the incidence of infection, demonstrating the widespread world-wide prevalence of this 
infection in humans. It also allowed the identification of clinical signs compatible with the 
diagnosis of congenital toxoplasmosis (Sabin and Feldman, 1948; Feldman and Miller, 1956). As 
such, Sabin determined that the simultaneous occurrence of clinical signs of hydrocephalus or 
microcephalus, intracerebral calcification and chorioretinitis, could be used to identify cases of 
congenital toxoplasmosis, what is nowadays known as the classical triad of symptoms of 
congenital toxoplasmosis (Sabin, 1941, 1942). 
In 1965 Desmonts and colleagues confirmed the transmission by the carnivorous route, 
which had been previously presupposed by Weinman and Chandler (Weinman and Chandler, 
1954) and by Jacobs et al. (1960). In 1972, Wallace and his colleagues began epidemiological 
surveys in regions where habitants ate raw or undercooked meat and observed a high frequency 
of infection in humans, demonstrating the transmission route through carnivorism. Anteriorly in 
1969, Kean et al. described the first outbreak of toxoplasmosis in Cornell University medical 
students after eating insufficiently cooked hamburgers. However, in 1959 Rawal in a study in 
vegetarians observed a frequency equivalent to that found in carnivores, and the diffusion of the 
parasitizes in this group was not clarified. In 1970 the cycle of this parasite is definitively clarified, 
with the discovery by Dubey et al. of the sexual development of T. gondii in the intestine of cats 
(Frenkel et al., 1970), thus felids are still presumed to be the only definitive host. An important 
step in the history of T. gondii occurred in the 1980’s when AIDS patients were found to develop 
clinical symptoms of the parasite (Luft and Remington, 1992). T. gondii was identified as a major 
opportunistic infection for these immunocompromised patients, where either newly acquired 
infection or recrudescence of latent infection would frequently cause encephalitis (Luft and 
Remington, 1992). 
The most recent developments for T. gondii are its possible effect on behavior changes in 
both animals (Berdoy et al., 2000; Ingram et al., 2013), and humans. Although the link to T. 
gondii infection and behavioral problems in humans is not completely clear, several reports have 
associated infection to schizophrenia (Torrey et al., 2012), increased risk taking and road traffic 
accidents (Flegr et al., 2009) and an increased risk of suicide (Lester, 2012). Also, the emergence 
of genetically different strains of the parasite have been linked to several fatal cases of acquired 
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infection in immuno-competent individuals (Carme et al., 2002, 2009; Ajzenberg et al., 2016), 
further highlighting the potential public health risk of the parasite.  
According to the current taxonomic classification, T. gondii belongs to the Kingdom 
Protista, sub - Kingdom Protozoa (Goldfuss, 1918), Phylum Apicomplexa (Levine, 1970), Class 
Sporozoasida (Leukart, 1879), Subclass Coccidiasina (Leukart, 1879), Order Eimeriorina (Leger, 
1911), Family Toxoplasmatidae (Biocca, 1956) (Hill et al., 2005; Dubey, 2010) and genus 
Toxoplasma (Nicolle and Manceaux, 1909). There is only one species, T. gondii; one of the most 
successful parasitic organisms.  
 
1.1.2. Biology 
There are three infective stages of T. gondii: a rapidly dividing invasive tachyzoite   
(Figure 1.1), a slowly dividing bradyzoite in tissue cysts, and an environmental stage, the 
sporozoite, protected inside an oocyst (Figure 1.2). Tachyzoites are crescent-shaped cells, 
approximately 5 m long and 2 m wide, with a pointed apical end and a round posterior end. 
They are limited by a complex membrane, named the pellicle, closely connected with a 
cytoskeleton involved in the structural integrity and motility of the cell. They possess a nucleus, 
a mitochondria, a Golgi complex, ribosomes, an endoplasmic reticulum, and a multiple -
membrane-bound plastid-like organelle called the apicoplast (Roos et al., 1999). As other 
members of the phylum Apicomplexa, they concentrate in their apical area a specialized 
cytoskeletal structure (the conoid, implicated in cell invasion) and numerous secretory organelles 
(rhoptries [ROPs], dense granules, and micronemes). Tachyzoites are the dissemination form and 
they are able to invade cells of all vertebrate, where they multiply in a parasitophorous vacuole. 
Bradyzoites result from the conversion of tachyzoites into a slow-dividing stage and form tissue 
cysts. These cysts are spheroid in brain cells or elongated in muscular cells, vary in size and can 
contain only two bradyzoites or thousands with a latent metabolism. Cysts remain intracellular 
throughout their lifetime and the death of the host cell may produce the disruption of the cyst wall 
and the consequent liberation of bradyzoites. The resistance of bradyzoites to the acid pepsin (1- 
to 2-h survival into pepsin-HCl) allows their transmission through ingestion. Oocysts are ovoid 
structures with two sporocysts (after sporulation) and with an exceptionally resistant double wall 
that enables the parasite to survive for long periods in adverse conditions. (Robert-Gangneux and 
Dardé, 2012). 
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Figure 1.1 Graphic representation of a tachyzoite. 
Image source: VectorStock.com/11563382. 
 
 
 
Figure 1.2 A) Bradyzoites inside a cyst of a laboratory mouse brain (100x, 40x e 10x objective), B) Free 
stained tachyzoites on laboratory mouse ascites , C) Sporolated and unsporulated Oocysts.  
Image source: National Reference Laboratory of Parasitic and Fungal Infections. 
 
 
1.1.3. Life cycle 
The life cycle of the parasite was fully understood with the discovery of T. gondii oocysts 
in cat faeces (Hutchison et al., 1969, 1971) it evidenced the central role of the cat as the only 
definitive host harboring the sexual developmental stages within the small intestine and spreading 
millions of oocysts through feces to the environment. The life cycle (Figure 1.3) consists of 
asexual reproduction in the intermediate hosts (including humans) and sexual reproduction in the 
intestinal mucosa of the definitive host. A unique feature that characterizes T. gondii life cycle is 
that it can be transmitted not only between intermediate and definitive hosts (sexual cycle) but 
also between intermediate hosts via carnivorism (asexual cycle) or even between definitive hosts. 
Oocysts take 3-7 days to sporulate in the environment and become infective by meiosis process 
leading to the formation of a sporulated oocyst with two sporocysts, each containing four haploid 
sporozoites (Holliman et al., 2003). Intermediate hosts in nature (including birds and rodents) 
become infected after ingesting soil, water or plant material contaminated with these oocysts. 
After oocyst ingestion, sporozoites are released and penetrate the intestinal epithelium. Then, they 
transform into tachyzoites and become surrounded by a parasitophorous vacuole that protects 
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them from host defense mechanisms. The tachyzoite multiplies asexually by endodygeny and 
they spread first to mesenteric lymph nodes and then to the several organs by invasion of the 
bloodstream (Hill et al., 2005; Jones and Dubey, 2010). After several multiplication cycles, 
tachyzoites give rise to bradyzoites, and tissue cysts arise as early as 7 to 10 days post infection 
and may remain throughout lifetime in the hosts, predominantly in the brain or muscles (Jones 
and Dubey, 2010; Dubey, 2010; Robert-Gangneux and Dardé, 2012). After the ingestion by a cat 
of cysts present in tissues of an intermediate host, gastric enzymes destroy the cyst wall. 
Bradyzoites settle within enterocytes, where they undergo a number of asexual multiplications, 
with the development of merozoites within schizonts. This process is followed by the formation 
of male and female gametes (gametogony) (Ferguson, 2002). After fertilization, oocysts formed 
within enterocytes are released by the disruption of the cell and are excreted as unsporulated forms 
in cat feces. On the other hand, after the ingestion of the tissue cysts by an intermediate host 
through raw or undercooked meat, cysts are ruptured as they pass through the digestive tract, 
causing the release of bradyzoites. The bradyzoites will infect the intestinal epithelium of the new 
host and differentiate back into the rapidly dividing tachyzoite stage for dissemination throughout 
the body. In addition, if the acute phase occurs during pregnancy, the parasite can cross the 
placenta and infect the fetus (congenital transmission) (Robert-Gangneux and Dardé, 2012). 
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Figure 1.3 Life cycle of Toxoplasma gondii. Cats are the definitive host where sexual replication takes 
place. Following replication within enterocytes of the gut (merogony), male and female gametes are formed  
within the host cell. Fusion of gametes leads to the formation of diploid oocysts that are shed  in cat faeces 
and undergo meiosis in the environment to yield eight haploid progeny. Oocysts contaminate food and 
water, providing a route of infection for intermediate hosts. In the intermediate host (birds and rodents) 
asexual replication occurs. Acute infection is characterized by fast replicating tachyzoites that disseminate 
throughout the body. Differentiation to slow-growing bradyzoites within tissue cysts leads to long-term 
chronic infection. Ingestion of tissue cysts via omnivorous or carnivorous feeding can lead to transmission 
to other intermediate hosts or to cats, which re-initiates the sexual phase of the life cycle. Many animals  
serve as intermediate hosts, including farm animals. Humans become infected by eating undercooked meat  
containing tissue cysts or by the ingestion of oocysts in contaminated water (de Moura et al., 2006; Jones 
and Dubey, 2012). T. gondii can infect the brain and other organs as well as the foetus following a congenital 
infection. 
Image adapted from Hunter and Sibley. Nature Reviews Microbiology 2012 Nov;  10:766-778 (Hunter and 
Sibley, 2012). 
 
1.1.4. Mechanism of cell Invasion 
T. gondii is a successful parasite because it can spread across many biomes and species, 
and has developed specialized processes to invade and replicate efficiently within cells. It is an 
obligate intracellular parasite, implying that it cannot survive outside a cell, which provides the 
parasite a safe, secure home full of nutrients and a refuge from the immune system of the host 
(Tosh et al., 2016). Invasion is an active process based on parasite motility and the sequential 
secretion of proteins from specialized secretory organelles, the micronemes, the rhoptries, and the 
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dense granules. The micronemes and rhoptries are localized at the apical end of the parasite, where 
they function to form the anchor and tight junction to host cell (Huynh et al., 2006; Dlugonska, 
2008). Secreted dense granule synthesizes proteins to facilitate the remodeling of host processes 
to help replication of the parasite (Bougdour et al., 2014). A fourth organelle, the apicoplast that 
contains essential metabolic pathways is also envolved in the cell invasion process (Arisue and 
Hashimoto, 2015). T. gondii invasion starts with parasite attachment to the host cell plasma 
membrane. First, the parasite contacts its apical end to the plasmatic membrane of a cell and then 
secretes proteins that will promote parasite adhesion. It requires the calcium-dependent secretion 
of adhesins from micronemes, such as the microneme protein MIC2, which recognize host cell 
receptors and promote parasite reorientation and attachment. Cell invasion relies on a complex 
interaction between the host cell surface and the parasite, a process called gliding motility, a 
complex motor system promoted by actin-myosin interactions and dynamic rearrangements of 
the parasite cytoskeleton (Carruthers and Boothroyd, 2007). 
Entry is a rapid process (15 to 30 s), apical membrane antigen (AMA1) secreted from 
micronemes and the secretion of rhoptry (ROP) neck proteins (RONs) inserted into the host cell 
membrane (Dubremetz, 2007) plays part in the anchoring process and creation of a tight junction 
between the parasite and the host cell plasma membranes (Blader et al., 2015), called the moving 
junction. The moving junction complex (AMA1-RON2) allows for host cell membrane 
invagination and movement of the parasite into the cell (Dobrowolski and Sibley, 1996; 
Håkansson et al., 2001). When the parasite fully enters the host cell, it is covered by a membrane 
made of a conglomerate of host lipid bilayer and secreted parasite lipids and proteins, resulting in 
a specialized vacuole called the parasitophorous vacuole (PV) (Suss-Toby et al., 1996). Host 
transmembrane proteins and proteins found in lipid rafts are excluded during the formation of the 
PV (Blader et al., 2015). The PV will be the focal point of interaction with the host cell, through 
which the parasite will import nutrients and export secreted proteins to create an environment 
ready for replication (Blader and Koshy, 2014). Soon after invasion, the PV localizes in the 
perinuclear region and associates with several host organelles, including the endoplasmic 
reticulum, Golgi complex, and mitochondria (de Melo et al., 1992; Sinai et al., 1997; Walker et 
al., 2008). The formation of the nascent parasitophorous vacuole membrane (PVM) requires the 
secretion of proteins from the ROPs. ROP18 one of these proteins is associated with the cytosolic 
face of the PVM and exerts protein kinase activity, which has a profound effect on parasite growth 
and virulence (El Hajj et al., 2007), and ROP16 is able to manipulate host gene expression, 
affecting interleukin secretion (Laliberté and Carruthers, 2008). Within the PV, tachyzoites divide 
during a 6 to 9 h cycle, by endodyogeny and they exit the cell usually after 64 to 128 parasites 
have accumulated in the PV (Black and Boothroyd, 2000). The egress of T. gondii tachyzoites 
from the host cell is performed through the rupture of the PV and the host cell plasma membrane, 
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releasing free parasites in the medium an active process that is dependent upon a rise in the 
calcium concentration (Sibley, 2010). This process can be triggered by parasite produced abscisic 
acid or other vacuole acidification and/or by the NTPases segregation. Egress occurs within 
minutes and once outside the infected host cell, the parasites use gliding motility to move and 
invade a new cell (Håkansson et al., 1999; Heintzelman, 2015; Periz et al., 2017) (Figure 1.4). 
 
 
Figure 1.4: Mechanism of cell invasion.  
Image source: Clinical Microbiology Reviews (Robert-Gangneux and Dardé, 2012). 
 
 
1.1.5. The Genome 
T. gondii has a ~65 Mb genome, comprising of 14 chromosomes which range from 
approximately 2 Mb – 7.5 Mb as shown in Figure 1.5 (Khan et al., 2005). The genome is closely 
related to another apicomplexan protozoan parasite, Neospora caninum (N. Caninum), and it is 
thought that around 28 million years ago the two parasites diverged from a common ancestor, due 
to the speciation of the definitive hosts (cats - T. gondii, dogs - N. Caninum) (Reid et al., 2012). 
In comparison to other apiocomplexan parasites, such as Cyptosporidium parvum (C. Parvum) 
and Theileria parva (T. parva), the genome of T. gondii is significantly larger, it contains more 
introns, more predicted genes and has a lower gene density (Delbac et al., 2001). One possible 
reason for the difference in size compared to other apicomplexans can be due to the large number 
of secondary hosts which this parasite is able to establish within (Roos, 2005). In 2005, a 
composite genome map was derived from genetic crosses and linkage analysis of the three main 
archetypal T. gondii lineages (I, II, III) (Khan et al., 2005). The genetic linkage map that was 
generated identified 250 species specific markers, of which 12 are most commonly used for strain 
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genotyping by PCR-RFLP. The Figure 1.5 details each of these individual markers and also 
highlights markers which are strain specific and those which are present on all three archetypal 
strains. A fourth clonal lineage, designated haplotype 12, is largely confined to North America 
and more common in wild animals (Khan et al., 2011) was designated. Su and colleagues 
classified T. gondii strains into 15 different haplotypes, defining six major clades (Su et al., 2012). 
However, Minot and colleagues disagree with this theory (Minot et al., 2012). The online genome 
database ToxoDB (http://toxodb.org/toxo/) provides further detailed information about the 
genome and the functional genomics of T. gondii. It also provides genome sequence information 
(including the facility to BLAST sequences), gene expression and proteomics data (Gajria et al., 
2008), which helps support research on the parasite. The most recent study published in 2016 
compared four tissue-cyst forming coccidian parasites and showed that three of these organisms 
N. caninum , Hammondia hammondi and T. gondii have a similar total genome size of 62–65 Mb 
while the Sarcocystis neurona genome is larger due to expanded repeats and much larger introns. 
All four genomes have identical GC compositions and are predicted to encode from 7,000 to more 
than 8,000 genes located on 14 chromosomes, as with T. gondii. This work reveals that tandem 
amplification and diversification of secretory pathogenesis determinants is the primary 
characteristic that distinguishes the closely related genomes of these parasites and also disclosed 
that the unusual population structure of this parasite is characterized by clade-specific inheritance 
of large conserved haploblocks that are significantly enriched in tandemly clustered secretory 
pathogenesis determinants. The shared heritage of these conserved haploblocks, which show a 
different ancestry than the genome as a whole, may thus influence transmission, host range and 
pathogenicity (Lorenzi et al., 2016). 
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Figure 1.5 Genetic linkage maps for the 14 chromosomes of Toxoplasma gondii. Individual markers are 
shown to the right of the vertical bar and chromosome numbers are given above each map. Markers that 
map to the same node are indicated to the right of a solid vertical bar. The corresponding genetic distances 
between each node are given to the left of each map and the total sizes in cM are shown at the bottom of 
each chromosome. Polymorphisms that are unique to type I are shown in red, those unique to type II are 
shown in green, those unique to type III are shown in blue and markers that contain multiple polymorphism 
are shown in yellow. Maps were constructed using MAPMAKER from the analysis of 71 recombinant 
progeny using 250 genetic markers. Markers that include data analyzed by Southern blot a re followed by 
the suffix ‘.c’. 
Image source: Nucleic Acids Research, https://doi.org/10.1093/nar/gki604 (Khan et al., 2005). 
 
 
1.1.6. Genetic variation and disease severity 
T. gondii has not only the capacity to propagate asexually but also sexually in its feline 
definitive host. Therefore, sexual recombination should provide for a high genetic diversity  
between T. gondii strains worldwide. However, the population structure of this parasite was 
initially described as being highly clonal and showing a low genetic diversity. Genotyping studies 
of T. gondii started in the 1990s and were based on a single marker, predominantly Sag2 (Howe 
et al., 1997; Fuentes et al., 2001; Sabaj et al., 2010) and GRA6 (Fazaeli et al., 2000; Messaritakis 
et al., 2008), but these methodologies didn’t allow the identification of non-clonal strains. Thus 
these methodologies were optimized in order to determine more precisely the presence of 
polymorphisms in the population and with the addition of new PCR-RFLP markers (Su et al., 
2006) and by microsatellite analysis (Ajzenberg et al., 2005, 2010), this was achieved. Genetic 
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studies of isolates from Europe and the United States suggested the presence of a clonal 
population structure stable in time and space (Darde et al., 1988; Sibley and Boothroyd, 1992; 
Howe and Sibley, 1995; Ajzenberg et al., 2002a; Khan et al., 2007) where the majority of isolates 
(> 94 %) are grouped into three main clonal multilocus genotypes I, II and III. This simple clonal 
structure is accompanied by a low level of genetic divergence among the three lineages (only 1 
to 2 % divergence at the DNA sequence level between lineages). However, multilocus and 
multichromosome genotyping of isolates from other continents revealed a much more complex 
population structure with a greater genetic diversity, likely reflecting a history of more frequent 
genetic exchanges and genetic drift (Lehmann et al., 2004; Ajzenberg et al., 2004) (Table 1.1). 
The majority of isolates from South America, Africa and Asia are not included in the three major 
lineages (with the exception of type III, which is really cosmopolitan). These deferent genotypes 
lead to the description of new haplogroups, some of them largely distributed over continents, 
being considered other successful clonal lineages (Khan et al., 2007). So far, 12 haplogroups 
(including the 3 initially described lineages, types I, II, and III) have been described (Khan et al., 
2007, 2011), based on sequence-based analyses, but these haplogroups are not totally 
homogenous, and more specific markers revealed subclustering that may be associated with 
geographical origins and phenotypic characteristics. Based on the classical genotyping, from 
Northern (Jokelainen et al., 2011) to Southern Europe (De Sousa et al., 2006), the population 
structure of T. gondii shows a clonal profile, with a predominance of the type II lineage strains. 
The other two clonal lineages are sporadically found in Europe. While the three clonal lineages 
predominate in North America and Europe, strains from other regions in the world appear to have 
genotypes that are more diverse. By analyzing isolates from South America, Asia and Africa by 
using PCR-RFLP or microsatellite markers, it was revealed that the majority of these isolates 
have the classical type I, II, and III alleles identical to those in the main three lineages, but some 
novel alleles were also detected. These ‘new’ genotypes were designated as atypical, exotic, 
recombinant or non-archetypal genotypes (Grigg et al., 2001a; Ajzenberg et al., 2004). The 
recombinant genotypes have mixtures of classical alleles, while atypical, unusual, non-
archetypical or exotic strains are characterized by the existence of many unique polymorphisms 
and novel alleles (Grigg et al., 2001a; Su et al., 2003; Ajzenberg et al., 2004). Phylogenetic 
analysis, based on microsatellites, suggests that these atypical genotypes are phylogenetically 
disseminated with no clear structure, or association with the main three lineages. Although there 
is clear divergence among these strains, essentially due to the mixture of alleles, the overall level 
of sequence polymorphism provided by single nucleotide polymorphisms is modest. (Grigg et al., 
2001a; Su et al., 2003; Ajzenberg et al., 2004). The isolation of atypical strains, which do not fit 
into these three major lineages, is rare in Europe and likely suggests contamination by non-
European strains either during residence abroad or after the consumption of imported food 
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(Ajzenberg et al., 2009). In North America, the population structure appeared similar to that 
observed in Europe, with a predominance of type II strains (Howe and Sibley, 1995). South 
America is an area with a high level of diversity for T. gondii and type II seems to be very rare 
(Dubey et al., 2007a). The high level of genetic diversity observed in this continent is maximal 
in the wild Amazonian area, with many unique polymorphisms (Ajzenberg et al., 2004). It is 
believed that, in the Amazonia area, the interpenetration of anthropized and wild rainforest 
environments leads to hybridization between strains that may represent a potential risk for human 
health. In Asia, it has been shown that strains have more limited genetic diversity compared to 
South America (Dubey et al., 2007b). Isolates from Cameroon that were analyzed via 
microsatellites revealed the existence of fixed combination of type I and III alleles, suggesting a 
unique clonal African type (Ajzenberg et al., 2004).  
Epidemiological studies have shown that type I strains are rare in human and animal 
infections, however has been linked to reactivation of the parasite in immunocompromised 
individuals (Khan et al., 2005) and type II strains are considered to be the most common source 
of human toxoplasmosis (Howe and Sibley, 1995). In North America and Europe, most cases of 
human toxoplasmosis in AIDS and congenital infections are associated with type II strains (Howe 
and Sibley, 1995; Howe et al., 1997; Ajzenberg et al., 2002a). However, a study in Spain reported 
dominance of type II strains in AIDS patients, while type I strains were associated with congenital 
infections (Fuentes et al., 2001). Another study from the USA revealed the relationship between 
severe ocular toxoplasmosis in immnunocompetent patients and type I strains and new 
recombinant genotypes (Grigg et al., 2001a). The severity of T. gondii acute infection is 
considered to be one of the most significant phenotypes among T. gondii strains. Very little is 
known concerning circulating strains in Portugal, a small scale study was  performed in France 
with Portuguese sera that reported a majority of type II humans strains (Sousa et al., 2008; 
Ajzenberg et al., 2009) and  other European study that enrolled only two Portuguese isolates 
(Ajzenberg et al., 2009) revelled that were both type II. 
The technological development accompanied with the cost reduction of the Whole Genome 
Sequence (WGS) methodology will allow in mid-term the sequencing of multiple complete 
genomes of T. gondii, allowing understanding of the real degree of genetic variability of this 
protozoan, frequency of recombination and potential genotype - phenotype associations. 
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Table 1.1 Geographical distribution of Toxoplasma gondii genotypes and potential relationships with  
human disease. 
Table Source: Adapted from Clinical Microbiology Reviews (Robert-Gangneux and Dardé, 2012). 
 
Geographical 
area 
Genotypes  Clinical features of human Toxoplasmosis  
Europe 
 
Type II (haplogroup 2), highly 
predominant; 
Type III, more in South; 
Other genotypes sporadically observed  
Asymptomatic or benign disease in 
immunocompetent individuals associated 
with type II or III; 
retinochoroiditis in immunocompetent 
patients  
North 
America 
Type II (haplogroup 2); Haplogroup 12; 
Type III (haplogroup 3); 
Other genotypes  
Asymptomatic or benign disease in 
immunocompetent individuals associated 
with type II or III 
South and 
Central 
America 
Africa (haplogroup 6); 
Type II occasionally; 
Type I rarely; 
Highly atypical genotypes in the 
Amazonian forest 
Higher rate and severity of retinochoroiditis 
in immunocompetent patients and in those 
with congenital toxoplasmosis; 
disseminated, potentially lethal, cases 
observed with the most atypical genotypes  
Africa 
African 1, 2, 3 (haplogroup 6); 
Type III (haplogroup 3); 
Type II 
Higher rate of retinochoroiditis  than in 
Europe 
Asia Type III (haplogroup 3); No data 
 
 
1.1.7. Assessment of strain virulence  
Experimental virulence is usually defined with the mouse model after the intraperitoneal 
inoculation with a given number of tachyzoites. Type I strains are highly virulent, have a lethal 
dose (LD100) (the minimal dose which causes 100 % mortality) of a single infectious organism, 
leading to the death of mice less than 10 days after the inoculation of about 10 tachyzoites. On 
the other hand, mouse non virulent strains, normally from type II and III, have a lethal dose of  
> 10 infectious organisms and usually generate chronic infection in the mouse (Sibley et al., 
2002). Isolates from other clonal lineages or from atypical strains range from the highly virulent 
to the intermediate or non-virulent phenotype, according to differences in the combination of 
genes that they have inherited. Genotypes with a majority of type I alleles are usually more 
virulent (Saeij et al., 2005a) The mouse-virulent strains exhibit some characteristics that may 
explain the rapid dissemination of the parasite and the higher tissue burden observed in mice and 
other susceptible hosts: improved migration across polarized epithelia or across the extracellular 
matrix, higher rates of the ex vivo penetration of the lamina propria of mucosa and submucosa 
(Barragan and Sibley, 2002), and in cell culture, higher growth rates and lower rates of 
interconversion from tachyzoites to bradyzoites. Experimental crosses between strains with 
different virulence patterns facilitated the identification of several polymorphic genes coding for 
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secreted factors of T. gondii associated with differences in the expression of virulence in mice 
(Taylor et al., 2006; Reese et al., 2011). These key virulence factors are secretory proteins 
discharged from apical organelles, the rhoptries. The proteins of this rhoptry family (ROP5, 
ROP16, and ROP18) exert kinase or pseudokinase activity. They are injected directly into the 
host cell and play a role during the process of parasite invasion or in the induction of interleukin-
12 (IL-12) secretion by mouse macrophages (Robben et al., 2004). 
T. gondii is considered to be a successful organism because it has the ability to cross 
biological barriers such as blood-brain barrier, placenta, or gut epithelium (Saeij et al., 2005a). 
However, the expression of virulence in humans is a complex phenomenon due to many other 
factors that may influence the pathogenicity of a given strain, namely: parasitic factors such as 
the infectious stage, the inoculums and the genetic background of the strain and immune status of 
the host. (Robert-Gangneux and Dardé, 2012). 
 
1.2. Toxoplasmosis, the human disease 
1.2.1. Pathophysiology 
Toxoplasmosis is the infectious disease caused by T. gondii. The pathophysiology of this 
infection results from the dissemination of tachyzoites throughout the body. Tachyzoites speedily 
invade monocytes and gain access to the blood flow (after trans-epithelial passage across the 
intestinal barrier) and from there to all organs (Robert-Gangneux and Dardé, 2012). In acute 
toxoplasmosis, a host may die due to necrosis (caused by intracellular growth of tachyzoites) of 
the intestine and mesenteric lymph nodes before severe damage of other organs. Focal areas of 
necrosis may develop in many organs; the clinical picture is determined by the extent of injury to 
these organs, especially vital organs such as the eyes, heart, and adrenals (Dubey, 2010). If the 
host survives, the invasive stages (tachyzoites) convert into a latent form (bradyzoites) within 
cells and persist as cysts, generally in muscles, retina, and brain, for a lifetime following the onset 
of an efficient immune response. The immunity is predominantly cell mediated and activated 
macrophages and T cells play a central role, while interferon gama (y) and other cytokines induce 
an effective immune response. The specific antibody in the presence of complement eliminates 
extracellular parasites (Holliman et al., 2003). 
 
1.2.2. Transmission 
Human infection is acquired by ingestion of tissue cysts in raw, poorly cooked or cured 
meat, notably lamb and pork. Consumption of meat from warm blooded animals is considered the 
major source of infection in Western countries (Cook et al., 2000). The transmission can occur 
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also by or ingestion of sporulated oocysts derived from contaminating soil, water or inadequately 
washed vegetables / fruit or directly from cat faeces. Once sporulated, oocysts are resistant to 
adverse environmental conditions, it can remain viable in a moist environment for more than a 
year, in very low (icy) or high water temperatures for long periods of time and can resist to 
chemical and physical treatments currently applied in water treatment plants, including 
chlorination and ozone treatment (Dumètre et al., 2008). When primary infection is acquired by 
a pregnant woman, tachyzoites can colonize placental tissues during the dissemination process 
and access the foetus. The risk of transmission and the severity of disease depend on the 
gestational stage at which the mother first becomes infected. Congenital infection is the most 
important part of the disease burden due to T. gondii infection in humans.  
Rarely, infection can be acquired via an organ transplant, as cysts can be found potentially 
in any organ T. gondii infection can be transmitted through a cyst-containing organ from a donor 
with infection acquired in the past to a nonimmunized recipient (Robert-Gangneux and Dardé, 
2012). One the other hand toxoplasmosis associated with bone marrow transplant is a rare event 
and is usually due to reactivation of the recipients previously quiescent chronic infection.  
(Holliman et al., 2003). As well as the transmission by blood transfusion because the duration of 
parasitemia following acute infection is limited. The eye can be reached by T. gondii via the 
bloodstream in the form of free tachyzoites or as tachyzoites that exist in circulating leukocytes 
(Roberts and McLeod, 1999). These establish in the retina and form cysts. Pathology occurs due 
to the release of tachyzoites as a consequence of the rupture of tissue cysts which result in invasion 
and inflammation of the retina. Another rarely event and not significant from an epidemiological 
point of view is the transmission by the consumption of unpasteurized goat’s milk (Tenter, 2000).  
 
1.2.3. Clinical Features 
1.2.3.1. The immonocompetent patient 
Primary infection of T. gondii is asymptomatic and passes unnoticed in the majority of 
immunocompetent patients. (Holliman et al., 2003) Nevertheless in some cases the symptomatic 
infection can occur being the most common presentation fever, muscle weakness and painless 
cervical or occipital lymphadenopathy in the form of lymph node enlargement without tenderness 
or suppuration for about 4 - 6 weeks or even months in some cases (Ho-Yen, 2009). Infected 
humans remain infected for their whole lives and cysts persist a life-long threat to the individua l.  
Parasite reactivation can occur as a result of immunosuppressive factors such as AIDS, or 
medication for inflammatory disease or transplantations (Porter and Sande, 1992). 
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1.2.3.2. The immunosuppressed patient 
When for any reason an immunosuppression happens, the opportunistic reactivation of a 
latent T. gondii infection can occur. AIDS patients and transplant recipients constitute examples 
of this. Toxoplasmosis is the most common cause of focal brain lesions and one of the most 
frequent opportunistic infections in AIDS patients leading to a fatal outcome and representing a 
life-threatening disease. Central Nervous System (CNS) lesions are caused by tissue destruction 
as a result of tachyzoite proliferation yielding immunopathologic effects caused by inflammatory 
response (Denkers and Gazzinelli, 1998). It has been shown that the existence of encysted 
bradyzoites in the CNS is associated with high incidence of toxoplasmic encephalitis in these 
individuals (Denkers and Gazzinelli, 1998). In the beginning of HIV emergence, prior to the 
development of anti-viral therapy, it was found that toxoplasmic encephalitis developed in about 
10-50 % of AIDS patients with chronic T. gondii infection (McCabe and Remington, 1988). In 
addition, the parasite can reactivate in the eye causing retinochoroiditis, or in the lung causing 
pneumonitis and acute respiratory failure (Luft and Remington, 1992; Ho-Yen, 2009).  
Toxoplasmosis represents a life threading complication to organ graft recipients being the 
most common transplanted organs, the heart, lung, liver and kidney. The infected recipients 
develop fever, deterioration of consciousness and signs of respiratory failure usually 3-5 weeks 
after the surgery. 
 
1.2.3.3. Ocular disease 
Ocular toxoplasmosis is one of the most common sequelae of chronic toxoplasmosis and 
presents in the form of retinochoroiditis with the presence of typical lesions, which are white focal 
lesions often associated with a vitreous inflammatory reaction. It can occur in congenitally or 
post-natal acquired infection resulting from acute infection or reactivation of dormant infection. 
However, ocular toxoplasmosis is more commonly associated with congenital infection (Brézin 
et al., 1994). Reactivation of infection and retinal disease in individuals with acquired, rather than 
non-congenital, toxoplasmosis is associated in some cases with reduction of immunity (Nicholson 
and Wolchok, 1976; Holland et al., 1988). In addition, it has been suggested that ocular 
toxoplasmosis can occur through transmission from the brain to the eye through the optic nerve 
(Mets et al., 1996). Furthermore, the development of tissue cysts that contain bradyzoites inside 
the eye can be involved in the reactivation of toxoplasmosis and is considered to be a significant 
feature in toxoplasmic retinochoroiditis pathogenesis which causes acute inflammation and can 
result in retinal scars that might cause blurred vision or blindness (Roberts and McLeod, 1999). 
Ocular infection can be manifested as pain, tearing, photophobia and finally loss of vision 
(Montoya and Remington, 1996; Holland, 2003, 2004; Ho-Yen, 2009). 
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1.2.3.4. Congenital toxoplasmosis 
T. gondii infection can be transmitted congenitally if the mother acquires the infection 
during pregnancy, as parasites cross the placenta and infect the foetus. The risk of infection being 
passed to the foetus increases as gestation progresses, however, inversely, the severity of disease 
decreases with an increase in gestation period (Dunn et al., 1999; Cook et al., 2000). Without 
treatment of the mother during pregnancy, the incidence of acquired foetal infection during the 
first trimester is 10 % - 15 %, in the second trimester is 30 % and in the third is 60 % (Wong and 
Remington, 1994). If the mother receives treatment with spiramycin, these incidences decrease to 
4.5 %, 17.3 % and 28.9 %, respectively (Wong and Remington, 1994). Congenital infection can 
occasionally result from reactivation of infection in immunosuppressed women if acquired before 
pregnancy (Wong and Remington, 1994). The variety of manifestations of congenital infection 
that occur in the foetus and in infants include spontaneous abortion, still-birth, a live infant with 
classic signs of congenital toxoplasmosis such as hydrocephalus or microcephalus, cerebral 
calcifications, mental retardation, seizures and retinochoroiditis (Hill and Dubey, 2002). The 
majority of cases are asymptomatic at birth, but most will develop neurological or ocular 
manifestations later in their lives. (Figure 1.6)  
 
  
Figure 1.6: Clinical signs A) cerebral calcifications, B) Retina lesions due to ocular toxoplasmosis ,C) 
Newborn with hydrocephalus. 
Image source http://wiki.ggc.edu/wiki/toxoplasma_gondii 
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1.2.4. The Diagnosis 
In most instances the non specific nature of the signs and symptoms of toxoplasmosis do 
not permit reliable diagnosis based only on the clinical findings. Its detection depends mainly on 
biological, serological, or histological methods or on the combination of some of these methods 
(Hill et al., 2005). However due to the diversity of T. gondii infection, investigations must be 
selected which are appropriated to that patient group. (Holliman et al., 2003) 
 
1.2.4.1. The immonocompetent patient 
The diagnosis of T. gondii infection in immunocompetent subjects relies on serology. As 
the infection is often asymptomatic, serologic diagnosis is usually retrospective and is used to 
determine the immune status. Available serologic procedures for the detection of T. gondii 
humoral antibodies include; the Sabin-Feldman dye test (DT), the modified agglutination test 
(MAT), the indirect hemagglutination test (IHAT) the indirect fluorescent antibody assay (IFA), 
the direct agglutination test (DAT), the latex agglutination test (LAT), the enzyme-linked 
immunosorbent assay (ELISA), and the immunosorbent agglutination assay test (IAAT). The 
IFA, IAAT, and ELISA tests have been modified to detect IgM antibodies (Remington et al., 
1995). Immunosorbent agglutination assays (ISAGAs) are also suitable for IgM, IgA, or IgE 
detection. The methylene blue dye test for the detection of antibodies, introduced in 1948 by Sabin 
and Feldman, is maintained as a gold standard for serology tests by reference laboratories, but is 
labor-intensive and requires a continual supply of live organisms. 
Immunoglobulin A and IgM  are produced during the first week following infection and 
reach a plateau within one month, these antibodies appear sooner than the IgG antibodies and 
disappear faster than IgG antibodies after recovery (Remington et al., 1995). Specfic IgE 
antibodies are also produced early and rapidly disappear. Specific IgM antibodies typically 
decrease after one to six months and disappear in 25 % of patients within less than seven months 
but commonly remain detectable for a year or longer with the most sensitive methodologies such 
as the ISAGA. Concerning that IgG antibodies are synthesized 1 to 3 weeks after the initial rise 
in IgM levels, IgG synthesis reaches a plateau within 2 or 3 months, then decreases and then 
persists lifelong as residual titers. Since IgG can persist for the life time, IgM, which typically 
persists for 1 - 6 months, is used as a marker of recent infection, (Wilson and McAuley, 1999).   
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1.2.4.2. The immunosuppressed patient  
Diagnosis of organ donor or transplant recipient and HIV patient  
Since acute toxoplasmosis in immunocompromised patients can be rapidly lethal, its 
diagnosis is an emergency. Whether serology is essential to estimate whether the patient is at risk 
for a reactivation of infection, evidence of evolutive infection is provided by the demonstration 
of tachyzoites in fluids or tissues by PCR or microscopic examination. In spite of be a highly 
sensitive method, in this case mice inoculation is not the first line of diagnosis because the time 
consuming. Several samples can be collected according to clinical signs and the type of 
immunosuppression. In transplant patients, where disseminated toxoplasmosis is frequent, 
parasites can be detected in bronchoalveolar lavage fluid (BAL), blood, bone marrow aspirate, 
cerebrospinal fluid (CSF), or virtually any biopsy specimen from a deep site. In HIV patients the 
most frequent presentation of this infection is the cerebral toxoplasmosis and the most effective 
approach is to perform PCR in CSF and blood. 
 
1.2.4.3. Ocular disease 
The diagnosis of retinochoroiditis is based on an ophthalmological examination together 
with PCR detection of T. gondii DNA in aqueous humor or vitreous fluid.  
 
1.2.4.4. Congenital Toxoplasmosis 
Prenatal diagnosis and follow-up of pregnancy  
Maternal infection during pregnancy is confirmed by serological methods and performed a 
puncture of amniotic fluid (AM) after 16 / 18 weeks of gestation and at least 4 weeks after 
maternal infection. Prenatal diagnosis relies mostly on the PCR based detection of parasite, DNA 
targets include the 110 copies ITS1 region of T. gondii (Tenter et al., 1994; Hurtado et al., 2001), 
the 35 copies B1 region (Burg et al., 1989) and the 300 copies 529 bp repeat element (Homan et 
al., 2000) but in most reference laboratories, amniotic fluid is also inoculated in mice. This in 
vivo assay relies on the animal inoculation with the AM and then the detection of an antibody 
response in the animals by the examination of mice serum samples by direct agglutination on 10 
days, 3 weeks and 6 weeks after inoculation. Finally, microscopic identification of the parasite 
tissue cysts in the mouse brain is performed in order to confirm the presence of brain cyst i.e. a 
positive result. 
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Postnatal diagnosis and follow-up of newborns  
At birth, the neonate undergoes a complete clinical and neurological health check. In order 
to detect cerebral calcifications a transfontanellar ultrasound examination is performed followed 
by a computed tomography in the case of observed abnormalities. During the first week of life an 
examination of the ocular fundus is performed and is repeated every 3 or 4 months. Follow- up 
of newborns is essential and is based on (i) parasite detection in placenta or newborn blood and 
(ii) serologic analysis of newborn serum to chek the presence of specific antibodies which would 
be evidence of a congenital infection. Serologic diagnosis commonly relies on the detection of 
specific antibody produced by the newborn. The detection of specific IgM or IgA antibodies, 
which cannot cross the placental barrier (to the exception of low molecular weight IgM) is a key 
marker of fetal infection. As maternal IgG is passively transferred in utero, this single assay can’t 
be a way to diagnosis of fetal infection. Consequently, a qualitative analysis is needed to 
differentiate between maternal antibodies and antibodies synthesized by the infected newborn, a 
comparative analysis of mother- and neonate-specific IgG/ low molecular weight IgM may help 
provide serologic evidence of fetal infection. This is allowed by the Immumoblot (IB) that 
perform a qualitative analysis of specific IgG or IgM by a comparison of band patterns, 
respectively, from paired mother-newborn sera in the first 2 or 3 months after birth. The 
parasitological examination of placenta and newborn blood at birth, is performed as in prenatal 
diagnosis, using mice inoculation, once more this in vivo assay relies on the animal inoculation 
with the placenta/ newborn blood and then the detection of an antibody response in the animals 
by the examination of mice serum samples by direct agglutination on 10 days, 3 weeks and 6 
weeks after inoculation. The detection of parasites in the placenta and/or newborn blood is the 
only evidence of congenital toxoplasmosis at birth (Robert-Gangneux et al., 2010).  
 
1.2.5. Prevention and Treatment 
Women during pregnancy or seronegative after conception and immunosupressed 
individuals should be given guidance to reduce the risk of acquiring toxoplasmosis. Fruit and 
vegetables should be washed properly, meats should be well cooked and hand wash after 
preparing raw meet should be emphasized. Gloves should be used when gardening or managing 
cat litters or cats directly. 
Treatment drugs for toxoplasmosis target the tachyzoite stage of the parasite and do not 
eradicate encysted parasites in the tissues. Pyrimethamine, considered the most effective drug 
against toxoplasmosis, is a folic acid antagonist and can cause suppression of the bone marrow, 
thus is administered with another folinic acid leucovorin that protects the bone marrow from the 
toxic effects of pyrimethamine. A second drug, such as sulfadiazine or clindamycin, should also 
be included.  
 Chapter I 
General Introduction 
 
 
23 
 
1.2.5.1. The immonocompetent patient 
The treatment is rarely indicated in adults with lymphadenopathic toxoplasmosis because 
this form of the disease is usually self-limited. If visceral disease is clinically evident or symptoms 
are severe or persistent, treatment may be indicated for 2 to 4 weeks (CDC). 
 
1.2.5.2. The immunosuppressed Patient 
Toxoplasmosis in immunodeficient patients is often fatal if not treated. Treatment is 
recommended for at least 4 to 6 weeks beyond resolution of all clinical signs and symptoms, but 
may be required for 6 months or longer. Relapses are known to occur in AIDS patients and 
maintenance therapy is recommended until a significant immunologic improvement is achieved 
in response to antiretroviral therapy. Pyrimethamine, folinic acid (leucovorin), and sulfadiazine 
are standards of therapy for immunodeficient patients (CDC). 
 
1.2.5.3. Ocular disease 
The treatment is dependent of acuteness of the lesion, degree of inflammation, visual acuity 
and size, location and persistence of the lesion. The classic therapy for ocular toxoplasmosis 
consists of pyrimethamine, sulfadiazine and folinic acid. (CDC) 
 
1.2.5.4. Congenital toxoplasmosis  
In general, spiramycin is recommended for women whose infections were acquired and 
diagnosed before 18 weeks gestation and infection of the fetus is not documented. Spiramycin 
acts to reduce transmission to the fetus and is most effective if initiated within 8 weeks of 
seroconversion. Pyrimethamine, sulfadiazine and folic acid are recommended for infections 
acquired after 18 weeks of gestation and infection in the fetus is a reality. Congenitally infected 
newborns are generally treated with pyrimethamine, a sulfonamide and folic acid for 12 months 
(CDC). 
 
1.2.6. Epidemiology and Burden of disease  
The prevalence of specific antibodies to T. gondii is directly proportional to the age of the 
individual and or a population, indicating that infection is acquired throughout life. The incidence 
of infection shows marked geographical variations and these differences are associated with diet, 
level of hygiene, host susceptibility, cat contact and climate (humidity of the soil). Consequently, 
toxoplasmosis is most common in warm, wet, with a large cat population areas and where meat 
is eaten light cooked or raw. Moist conditions can increase oocyst survival during long periods of 
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heat, which likely accounts for the high prevalence in tropical countries of South America and 
Africa. According to a review study (Pappas et al., 2009) the global status of T. gondii 
seroprevalence in women of reproductive age or pregnant ranged from above 60 % in countries 
such as Brazil, Gabon, Indonesia, Germany, and Iran, to less than 10 % in United Kingdom and 
Korea. Another recent review study which encompassed 88 countries (Flegr et al., 2014) showed 
that the lowest seroprevalence (1 %) was found in some countries in the Far East and the highest 
(90 %) in some parts of European and South American countries. In European countries, the 
prevalence ranges between 10 % to 60 % and in some regions as high as 90 %. Ingestion of raw, 
undercooked or cured meat is the primary risk factor in Europe (Holliman et al., 2003). 
Concerning the United States, the Center for Disease Control and Prevention (CDC) reported an 
overall seroprevalence of 11 %. In many developed countries, T. gondii seroprevalence declined 
sharply over the past three decades. (Cook et al., 2000; Gargaté et al., 2016) which may be 
associated with the practice of freezing meet, introduction of intensive farming techniques 
separating cats from livestock, and prevention strategies that includes elucidation of pregnant 
women and  immunocompromised individuals about the sources of infection. According to the 
last European Centre for Desease Prevention and Control (ECDC) Annual Epidemiological 
Report for 2016 of congenital toxoplasmosis data (ECDC, 2017), 242 confirmed cases of 
congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 81% of all 
confirmed cases due to the active screening of pregnant women. The notification rate was 6.7 
cases per 100 000 live births, with the highest rates in France (24.9) followed by Poland (5.2). In 
2016, gender was reported for 98 % of the congenital toxoplasmosis cases, with a male-to-female 
ratio of 1.1:1. Of 203 cases with known outcome, five were reported to have died, giving a case 
fatality of 2.5 %. No seasonal pattern was observed for this infection disease. 
Symptoms of toxoplasmosis can be lifelong, namely, children whose born with congenital 
toxoplasmosis or individuals with ocular toxoplasmosis (whether acquired postnatally or 
congenitally) which, at its most severe, can cause blindness. A small number of studies within 
Greece, Netherlands and the USA have studied the disease burden of foodborne pathogens, 
comparing organisms such as Campylobacter spp (Campylobacter), Salmonella enteric 
(Salmonella), Listeria monocytogenes (Listeria), Cryptosporidium parvum (C. parvum), 
Escherichia coli O157:H7 with T. gondii (Gkogka et al., 2011; Hoffmann et al., 2012; Havelaar 
et al., 2012; Batz et al., 2012). This research has taken into account the annual cost or disability 
of illness linking it to either quality-adjusted life-years (QALYs) or disability-adjusted life- years 
(DALYs). These findings showed that T. gondii ranked third, after Salmonella and 
Campylobacter, based on QALYs in the USA, and from representative data taken in 2009 from 
Netherlands, T. gondii ranked highest among 14 other foodborne pathogens when DALY’s were 
used to classify these pathogens. Other results from another study (Flegr et al., 2014) suggest that 
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the prevalence of toxoplasmosis in 88 countries is correlated with various disease burden 
measured with age standardized Disability Adjusted Life Years (DALY) or with age standardized 
mortality being the highest among all foodborne pathogens. According to a WHO study the global 
annual incidence of congenital toxoplasmosis was estimated to be 190 100 cases, this was 
equivalent to a burden of 1.20 million DALYs and high burdens were seen in South America and 
in some Middle Eastern and low-income countries (Torgerson and Mastroiacovo, 2013). The high 
disease burden reported in these publications highlights the lifelong effects that T. gondii can have 
on infected individuals. 
 
1.3. Sate of the Art before this work 
In Portugal, the last epidemiological data concerning T. gondi seroprevalence reported to 
1979, on behalf of the 1st National Serological Survey, and showed a global prevalence of 47 %, 
where the highest rates were obtained in the north and central Portuguese regions, and was higher 
in individuals above 15 years old (Ângelo, 1983). The small-scale serological studies conducted 
in the last years enrolled solely pregnant women and showed prevalence rates of approximately 
30 %. The deficit of the current epidemiological situation of toxoplasmosis in Portugal was 
recognized by the Directorate General of Health, which stated in Guideline Nº 37/2011 of 
30/09/2011 DGS that screening of toxoplasmosis should be performed in surveillance low risk 
pregnancies and that there was few data of the immune status of women in Portugal for 
toxoplasmosis. Thus, we believe that the evaluation of seroprevalence of this infection in 
Portuguese population is of great importance in public health because it allows us to infer the risk 
of infection, namely of pregnant women and of women in childbearing age, allowing health 
authorities to perform an effective prevention for this life threat infection.  
Genetic studies integrating intermediary and definitive hosts were lacking in Portugal, in 
spite of the three genotypes have already been described in animals, revealing a majority of type 
II strains (De Sousa et al., 2006; Dubey et al., 2006, 2007a). In humans there were only two 
evaluations regarding the genetic variability of T. gondii strains in Portugal (Sousa et al., 2008; 
Ajzenberg et al., 2009) which were limited and only one used the classical typing method, which 
hampers the comparison of the molecular epidemiology data with the scenarios from other 
countries. Thus, the understanding of the molecular epidemiology of T. gondii circulating strains 
in Portugal would certainly be useful to highlight the transmission routes and preview clinical 
presentation of the infection. 
According to the World Health Organization and Health Protection Agency guidelines, the 
gold standard methodology for the laboratory diagnosis of congenital toxoplasmosis is 
inoculation in mice of the diverse biological products. This methodology is also used for 
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maintaining/propagating the isolated strains in reference laboratories. However, this technique 
presents several disadvantages for the latter purpose. Indeed, it requires the sacrifice of many 
animals, which is badly seen in the light of animal welfare and is highly laborious and time 
consuming. In this way, it would be important to reduce the number of mice sacrificed in the in 
vivo model. 
 
1.4. Aims of this thesis 
According to this, the general goal of this PhD thesis is to contribute for the knowledge of 
toxoplasmosis in Portugal, by means of three specific objectives, each one constituting one 
distinct chapter of this thesis: 
i) to evaluate the prevalence and evolution of antibodies anti T. gondii in the Portuguese 
population by comparing three cross - sectional studies spanning three decades, 1979/80, 20/2003 
and 2013 (Chapter II); 
ii) to perform a genetic and virulence characterization of T. gondii strains isolated from the 
several biological samples from the population with suspected toxoplasmosis that attended to the 
NIH to perform the laboratorial diagnosis of T. gondii. And also to describe the demographic 
characteristics of the referred patients and estimated the rate of new cases in the last 10 years 
(Chapter III); 
iii) to evaluate the use of an in vitro system based on a cell-line for strain propagation, in 
order to replace, or at least reduce, the use of the demanding animal model and to assess the 
potential genotypic alterations throughout cell line propagation by New Generation Sequencing 
(Chapter IV). 
We believe the achievement of these objectives will contribute to enhance the knowledge 
of toxoplasmosis in Portugal, which will be ultimately beneficial for the control of T. gondii 
infections and its potentially tragic outcome for the newborns and immunosupressed patients.
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2. Toxoplasma gondii seroprevalence in the Portuguese population: 
comparison of three cross-sectional studies spanning three decades 
2.1. Abstract 
Toxoplasma gondii is an obligate intracellular protozoan infecting up to one-third of the 
world's population, constituting a life threat if transmitted from mother to child during pregnancy. 
In Portugal, there is a lack of knowledge of the current epidemiological situation, as the unique 
toxoplasmosis National Serological Survey was performed in 1979/1980. Methods: We studied 
the seroprevalence trends in the Portuguese general population over the past 3 decades, by 
assessing chronological spread cross-sectional studies, with special focus on women of 
childbearing age, by age group, region and gender. Results: The T. gondii overall seroprevalence 
decreased from 47 % in 1979/1980 to 22 % (95 % CI 20 % to 24 %) in 2013. Generally, we 
observed that the prevalence of T. gondii IgG increased significantly with age and it decreased 
over time, both in the general population and in the childbearing women (18 % prevalence in 
2013). Conclusions: The scenario observed for the latter indicates that more than 80 % of 
childbearing women are susceptible to primary infection yielding a risk of congenital 
toxoplasmosis and respective sequelae. Since there is no vaccine to prevent human toxoplasmosis, 
the improvement of primary prevention constitutes a major tool to avoid infection in such 
susceptible groups. 
 
Keywords  
 
Toxoplasma gondii; epidemiology; pregnancy; congenital toxoplasmosis; laboratory surveillance.  
 
2.2. Introduction 
Toxoplasma gondii is an obligate intracellular protozoan parasite belonging to phylum 
apicomplexa, which infects most mammals worldwide. It undergoes a sexual cycle in the 
intestinal epithelium of the definitive host, members of the cat family, therein  transforms into to 
oocysts which are subsequently shed in the environment, and an asexual cycle in an intermediate 
hosts, such as birds, rodents and other mammals including human beings. (Holliman et al., 2003) 
Oocysts are extremely stable in the environment, and are transmitted to other hosts through 
inadvertent ingestion. Humans acquire T. gondii through ingestion of tissue cysts in the 
undercooked meat of intermediate hosts, mainly pork and lamb, or by the ingestion of water or 
food contaminated by faeces containing oocysts from the definitive host, (Cook et al., 2000) and 
rarely through transplantation of a infected organ (Hill and Dubey, 2002). While toxoplasmosis 
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is often benign in immunocompetent individuals (revealing no symptoms or may experience 
swollen lymph glands), it induces major complications in immunocompromised individuals and 
during pregnancy, constituting a life-threatening disease; congenital toxoplasmosis (transmission 
to the foetus when a pregnant woman acquires T. gondii infection for the first time during 
pregnancy) can result in abortion or lead to severe malformation of the foetus, or to visual or 
neurological injuries in the newborn, such as  hydrocephalus, cerebral calcification and/or 
chorioretinitis. Such patients may require prolonged, sometimes life-long, therapy. Also, recent 
studies suggest that subtle behavioural or personality changes may occur in T. gondii infected 
humans, (Flegr, 2012) and toxoplasmosis has recently been associated with neurological 
disorders, particularly schizophrenia (Holub et al., 2013) and bipolar disorder (Tedla et al., 
2011). However, evidence for causal relationships remains limited (Webster et al., 2013).  
T. gondii has a wide spectrum of prevalence across the globe and infects up to one-third of 
the world's population (Tenter, 2000). Several decades ago the reported prevalence among general 
population elsewhere in the world varied from 0 % in Eskimos to 94 % in Costa Rican and 
Guatemalan (Gibson and Coleman, 1958; Feldman, 1982). Cultural habits in regard to cooking 
food are likely the major cause of differences in the frequency of infection with T. gondii in many 
areas of the world. Consequently, there are large differences in the incidence of congenital 
infection that may vary from 1:1000 live births in France, to 1:10 000 in countries with a lower 
seroprevalence, and in the USA, it has been estimated that ∼3500 infants are born each year with 
congenital toxoplasmosis (Feldman, 1982). According to a study review (Pappas et al., 2009) the 
global status of T. gondii seroprevalence in women of reproductive age or pregnant ranges from 
above 60 % in countries such as Brazil, Gabon, Indonesia, Germany, and Iran, to less than 10 % 
in United Kingdom and Korea. In many countries, T. gondii seroprevalence declined sharply over 
the past three decades (Cook et al., 2000). The surveillance schemes of toxoplasmosis are very 
heterogeneous in European countries, which hinders the burden of congenital toxoplasmosis 
estimates comparison (ECDC, 2013). The first National Serological Survey was conducted in 
continental Portugal between 1979 and 1980 and showed T. gondii overall seroprevalence of 47 
% (Ângelo, 1983). Since then, no National Serological Surveys enrolling T. gondii antibodies 
were performed, but only small-scale studies (Ângelo, 2003), (Machado, 2005) (Lopes et al., 
2013). Thus, Portuguese health national authorities consider that there is a lack of knowledge of 
the current epidemiological situation of toxoplasmosis in Portugal, and the 2011 guidelines of the 
General Directorate of Health for toxoplasmosis screening establish the surveillance of low-risk 
pregnancy based on three monthly retesting of susceptible women (Ministério da Saúde: Direção-
Geral da Saúde, 2011). Of note, congenital toxoplasmosis is a mandatory notifiable disease in 
Portugal (Saúde, 2014), and its diagnosis should be performed in our laboratory at the National 
Reference Laboratory of Parasitic and Fungal Infections of the Portuguese National Institute of 
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Health. In this regard, considering our data, there are about three cases of congenital 
toxoplasmosis per year in Portugal (data not published). Considering that the unique overall 
population study performed in Portugal dates back to 35 years ago, the aim of this study was to 
describe the seroprevalence trends in the Portuguese general population (with special focus on 
women of childbearing age) over the past three decades (1979 – 1980 to 2013), by age group, 
region and gender. 
 
2.3. Material and Methods 
2.3.1. Study design and sampling 
In order to fulfil the defined objectives, three cross-sectional seroprevalence studies 
(1979/1980, 2001/2002 and 2013) were used. All of them were based on opportunistic sampling. 
Nevertheless, few biases are associated with this strategy in our study, as sera belonged to 
individuals seeking diverse blood analysis rather than specific T. gondii evaluation, which also 
reflects the vast majority of the general population. Furthermore, the same methodology was 
applied to all three surveys, ensuring their internal validity by increasing their comparability. The 
starting point was the T. gondii serological data released on behalf of the First Portuguese National 
Serological Survey in 1979/1980. This sample enrolled 1675 individuals of both genders, which 
were homogeneously distributed by the following stage groups: 8 months - 5 years, 6 - 15, 16 - 
30, 31 - 45 and ≥ 46 years. Each age group included individuals from each of the 18 districts of 
Portugal (Portuguese islands were not included) that were representative of the population of each 
district (Ângelo, 1983). Then, in this study, we processed two distinct samples. The first one was 
composed of sera belonging to the Second Portuguese National Serological Survey 2001 - 2002 
that aimed to estimate the prevalence of antibodies to vaccine-preventable diseases, and for this 
reason, the determination of antibodies for toxoplasmosis was not performed at that time. This 
sample enrolled 3525 individuals of both genders, and covered all age groups. Similar to the first 
serological survey, each age group included a number of individuals representative of the 
population of each of the 18 districts. For the participation of individuals, a document was 
prepared with the objectives and benefits of the study and informed consent was obtained either 
from the participants themselves or from their legal representatives (Freitas and Paixão, 2004). 
From these sera, we used a subsample of 1657 sera, which was established to detect the difference 
in antibodies prevalence between the 1979/1980 and 2001/2002 Portuguese National Serological 
Surveys of at least 5 %, with a power of 80 % and a significance level of 5 %. This subsample 
comprehended individuals of both genders, homogeneously distributed in five age groups: 8 
months - 5 years, 6 - 15, 16 - 30, 31 - 45 and ≥ 46 years. Each age group included individuals 
from each of the 18 districts (as in previous surveys, proportion within districts was ensured). It 
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served as baseline for the establishment of the sample size of the 2013 T. gondii serological 
survey, which was composed of 1440 individuals of both genders, homogeneously distributed in 
the same five age groups as the previous survey. In each age group, for both surveys, individuals 
were distributed by 18 districts of Portugal (Portuguese islands were not included) proportionally 
to the resident population. For the 2013 survey, individuals were selected (to fulfil the above cited 
requisites of age, gender and geography) from the attendees of the private clinical laboratory of 
Dr Joaquim Chaves during the period of January to December 2013. This is the largest Portuguese 
laboratory comprehending more than 40 sampling collection units dispersed throughout the whole 
country. No informed consent was obtained from each participant as, besides the information 
regarding gender and age, no further information was available to the laboratory. This procedure 
is in agreement with the Portuguese law No. 12/2005. 
 
2.3.2. Serological analysis 
Sera regarding the 2001/2002 seroprevalence study were analysed for the presence of T. 
gondii-specific antibodies in 2012, whereas the analysis for the 2013 survey was performed in 
2013, both at the National Reference Laboratory of Parasitic and Fungal Infections of the 
Portuguese National Institute of Health (NIH). T. gondii IgG-specific antibodies were detected 
by using the automated methodology enzyme linked fluorescent assay-sensibility 99.65 % 
(interval confidence (CI) 94.55 % to 97.39 %), specificity 99.92 % (CI 99.58 % to 100 %) and 
cut-off 4 ≤ titre < 8 IU/mL, with the VIDAS TOXO IgGII commercial reagents (bioMérieux SA, 
Marcy-l’Étoile, France) according to the manufacturer's instructions. For the resolution of 
equivocal samples (ie, 4 ≤ titre < 8 IU/mL), we retested them using a manual methodology of the 
direct agglutination test-sensibility 96.22 % (CI 94.55 % to 97.39 %), specificity 98.80 % (CI 
96.46 % to 99.60 %) and cut-off 4 IU/mL, by using the TOXO-Screen DA commercial reagents 
(bioMérieux SA, Marcy-l’Étoile, France), according to the manufacturer's instructions. Most of 
the epidemiological surveys are based on the IgG titre because IgG antibody positive titres can be 
detected 2 - 3 weeks after infection, reaching a maximum titre within 2 months. It then declines 
to a baseline level that persists throughout the remainder of one's life. These methodologies were 
not available at the time the first National Epidemiological Survey was performed (1979/1980), 
which used an in house indirect immunofluorescence method (Ângelo, 1983).  
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2.3.3. Statistical analysis 
Statistical analysis consisted of the estimation of the seroprevalences among the categories 
of the variables sex, age groups and region. Differences between the estimated seroprevalences 
were analysed using the χ2test, considering the significance level of 5 %. The stats package of R 
software (V.3.0.3) was used (R Development Core Team. R: A language and environment for 
statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013. ISBN 3–
900051–07–0, URL. http://www.R-project.org). 
 
2.4. Results 
In the 2013 serological survey (n = 1440), we observed an overall prevalence of T. gondii 
antibodies of 22 % (95 % CI 20 % to 24 %), whereas in the 2001/2002 survey (n = 1657) the 
overall prevalence of T. gondii antibodies was 36 % (95 % CI 34 % to 39 %) (Figure 2.1A). The 
seroprevalence in the Portuguese population decreased by 11 % (95 % CI 7 % to 14 %) between 
1979/1980 and 2001/2002, 14 % (95 % CI 11 % to 17 %) between 2001/2002 and 2013, and 
25 % (95% CI 22% to 28%) between 1979/1980 and 2013. The significant decreasing trend during 
this 34 - year period is illustrated in Figure 2.1B. Since there were no statistically significant 
differences between the 18 districts (data not shown), we grouped them into four regions: north, 
centre, Lisbon area and south. In the 2013 survey, the seroprevalences ranged from 13 % (CI 95 
% 10 % to 17 %) in the north of Portugal to 33 % (CI 95 % 29 % to 37 %) in the south region 
(Table 2.1). 
Chapter II 
Toxoplasma gondii  seroprevalence in the Portuguese population: comparison of  three cross -sectional studies spanning three decades  
 
 
34 
   
Figure 2.1 (A and B) (A) shows the evolution of Toxoplasma gondii seroprevalence in Portugal over the 
past three decades; (B) shows the sample sizes for the three National Serological Surveys, the precise 
estimated seroprevalences and respective 95 % confidence interval (CI). 
 
Table 2.1 Trends of Toxoplasma gondii seroprevalence in Portugal by region calculated with an interval 
confidence of 95 %. 
 
This finding is in opposition to the ones observed for the serological surveys of 1979–1980 
and 2001/02, where the seroprevalence was higher in the north, centre and Lisbon area. In 
particular, the north region presented the highest levels in the first two surveys but the lowest in 
the last survey, in opposition to the south. In general, a decreasing trend was observed for the 
prevalence of T. gondii antibodies over the studied years in the four regions, with the exception 
of the south region that showed an increase of 8 % (95 % CI 2 % to 19 %) between 2001/2002 
 
 
n 
1979/80 
Seroprevalence 
(%) 
 
n 
2001/02 
Seroprevalence  
(%) 
 
n 
2013 
Seroprevalence 
(%) 
North 405 51 % (46% - 56%) 426 45% (41%- 50%) 464 13% (10% -17%) 
Centre 590 47% (43%- 51%) 426 38 % (0,33% -42%) 344 29 % (25%- 34%) 
Lisbon 302 47 % (41%- 52%) 630 33 % (29% -37%) 504 23% (20% -27%) 
South 378 43% (38% - 48%) 171 25 % (19% - 32%) 128 33 % (25% - 41%) 
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and 2013 (Tables 2.1 and 2.2). In particular, the decrease observed for the north region between 
these two surveys was statistically significant (Table 2.2) 
 
Table 2.2 Multivariate analysis adjusted for gender, age group and region. 
The values represent the prevalence ratios between the 2013 and the 2001 / 2002 serological surveys. 
Data are not available for the 1979/1980 survey. 
 
 
 
 
Regarding the association between seroprevalence and age, we observed that the 
prevalence of specific T. gondii IgG increased significantly with this variable for each age group 
(eg, for the 2013 survey, χ2 test for trend in proportions gives a p value < 0.001) and it generally 
decreased over time (Figure 2.2). The only exception occurred for the age group ≥ 46 that revealed 
an increase from the 1979/1980 to the 2001/2002 survey. Considering solely the last two surveys 
(no data are available for the 1979/1980 survey, except for females between 15 and 45 years of 
age), the prevalence of specific T. gondii IgG decreased significantly for all age groups (except 
for 8 months – 5 years) (Table 2.2). 
 
 Prevalence ratios from 2002 to 2013 
North 0.37 (0.28 – 0.50) 
Centre 0.93 (0.72 – 1.20) 
Lisbon 0.84 (0.67 – 1.06) 
South 1.27 (0.82 – 1.95) 
8 months - 5 years 0.60 (0.13 – 2.80) 
6 – 15 years 0.21 (0.07 – 0.64) 
16 – 30 years 0.52 (0.35 – 0.76) 
31 – 45 years 0.70 (0.52 – 0.94) 
>= 46 years 0.83 (0.70 – 0.99) 
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Figure 2.2 Comparison of Toxoplasma gondii seroprevalence trends, according to the data from three 
National Serological Surveys, by age groups. 
 
Concerning the seroprevalence distribution by gender, we observed no significant 
differences, either for the 2001/2002 or the 2013 survey. Both genders showed a significant 
decrease in prevalence between these two surveys (Table 2.3). 
 
Table 2.3 Toxoplasma gondii seroprevalence by gender and year of analysis calculated with an interval 
confidence of 95 %. 
  
 
 
 
Among the female population, we considered childbearing women aged 15–45 years, and 
observed a significant decreasing trend in the seroprevalence in this group: 53 % (95 % CI 48 % 
to 59 %) in 1979–1980, 35 % (95 % CI 32 % to 38 %) in 2001/2002 and 18 % (95 % CI 14 % to 
22 %) in 2013. We also subdivided this population into five groups: 15 - 20, 21 - 26, 27 - 32, 
33 - 38 and 39 - 45 years and observed that, like in the general population, there was a significant 
increase of T. gondii seroprevalence with age (except for a unique age group within the 1979 - 
1980 survey), and a significant decreasing trend over time (Table 2.4). 
 
 
 
 Male Female 
 n Prevalence % n Prevalence % 
2002 641 35% (31% -39%) 1016 38 % (35% - 41%) 
2013 638 22 % (19% -25%) 802 23 % (20% - 26%) 
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Table 2.4 Toxoplasma gondii seroprevalence in childbearing women by age group calculated with an 
interval confidence of 95 % 
 
 
 
 
2.5. Discussion 
In this study, we aimed to perform a cross-sectional T. gondii seroprevalence study in the 
Portuguese population. We acknowledge the following limitations in this serological study, 
namely: (1) the lack of more complete personal and socioeconomic and demographic information, 
hampering an evaluation involving risk factors; (2) the probable lower sensitivity and/or 
specificity of the serological tests used in the first national survey when compared with the ones 
used in the latest surveys; (3) the use of different serological methods (1979/1980 vs the two most 
recent surveys); and (4) the use of both fresh (1979/1980 and 2013 surveys) and frozen 
(2001/2002) sera. We believe that some of these limitations could impact some false-negative 
and/or false-positive results and quantitative data (ie, the determination of serological titres), but 
less significantly impacted the determination of the immune status of the enrolled people, which 
was beyond the scope of this study. Also, sensitivity and specificity of the conventional methods 
most likely changed little over the years, as demonstrated, for instance, by the maintenance of the 
gold standard (Sabin-Feldman dye test) over the past 60 years. Finally, interassay variability is 
very unlikely to explain the large changes in seroprevalence observed from 1979/1980 to the 2013 
survey. The 2013 serological survey established an overall prevalence of T. gondii-specific IgG 
of 22 %. This value indicates a prevalence that is similar to what has been described for other 
Mediterranean countries, such as Spain, Italy and Greece (Gutiérrez-Zufiaurre et al., 2004; Diza 
et al., 2005; de Ory Manchón, 2009; Pappas et al., 2009; Pinto et al., 2012; Mosti et al., 2013), 
which could be associated with the similarity between these countries in terms of: (1) climate: 
seroprevalence may depend on the appropriate conditions for sporulation and oocysts survival in 
the environment, as oocysts maturation and transmission to a new host is faster at mild and wet 
climates (Tassi, 2007), which are not characteristic of these countries; (2) cat contact: cats are one 
of the major sources of infection, as they shed a large amount of oocysts via faeces, indoors and 
 1979 2002 2013 
"15-20" 51% (41%-60%) 19% (14%-25%) 4% (2%-10%) 
"21-26" 56% (44%-67%) 23% (18%-30%) 10% (4%-19%) 
"27-32" 46% (35%-58%) 34% (28%-41%) 17% (10%-28%) 
"33-38" 60% (45%-72%) 48% (40%-56%) 32% (20%-49%) 
"39-45" 60% (47%-72%) 62% (53%-69%) 50% (37%-63%) 
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outdoors, even after ingestion of a single bradyzoite or one tissue cyst (Hill and Dubey, 2002; 
Dabritz and Conrad, 2010). More, sporulated oocysts can survive for years in water, gardens, 
beach sands and farms, which constitute environmental features that are typical of these countries, 
enabling similar means of transmission due to the contact with the abundant stray and domestic 
cats in these environments (Hill and Dubey, 2002; Dabritz and Conrad, 2010), and (3) diet, the 
ingestion of raw, undercooked or cured meats is the primary risk factor in Europe for acquiring 
toxoplasmosis (Holliman et al., 2003), and these countries present the same nutritional behaviour 
and eating habits, namely the traditional consumption of cured meats and raw vegetables. 
Although the frequent cat contact and typical diet would support higher seroprevalences than 
those observed, other factors, such as the climate and population education (discussed below), 
most likely balance this trend. We observed a huge decrease in the T. gondii seroprevalence in 
Portugal, from 1979/1980 to the 2013 survey, as the first survey revealed a 47% rate (Ângelo, 
1983), which was low compared with the values reported in France, but sharply high when 
compared with north European countries. Curiously, the 2013 prevalence (22 %) remains low 
compared with France but is now sharply lower compared with some countries from the north of 
Europe such as Germany, Poland, Belgium, the Netherlands and Switzerland (Pappas et al., 
2009). We speculate that a possible explanation for those striking differences may rely on cultural 
habits in regard to eating and cooking practices. The sharp decreasing trend of T. gondii 
seroprevalence observed in Portugal during the past 34 years has been also reported in many 
studies performed in several developed countries (Nowakowska et al., 2006c). Since the 
consumption of raw or undercooked meat is considered to be the major source of T. gondii 
infection, we believe that this decreasing trend may be associated with: (1) the practice of freezing 
meat; (2) the changes in nutritional habits that took place in Portugal and Europe during the past 
years related to the wide access to fast foods and pre-prepared meals, including frozen meat meals 
and the decreasing number of home-prepared meals (Nowakowska et al., 2006c); (3) the 
introduction of intensive farming techniques involving the separation of cats from livestock, 
coupled with the reduction of breeding cattle in backyards (Holliman et al., 2003; Nowakowska 
et al., 2006c); (4) the release of legislation for toxoplasmosis, concerning sanitary inspection in 
the slaughterhouses; and (5) the improvements in health education and information by health 
professionals, as the lack of awareness of disease sources of transmission is a crucial factor in the 
risk of infection. 
Regarding the distribution of T. gondii seroprevalence by geographic region, we observed 
an intriguing phenomenon as, contradicting the continuous decrease detected in the north, centre 
and Lisbon area, there was an 8 % increase (table 2.1) of the seroprevalence in the south, from 
2001–2002 to the 2013 survey. Also, in the 2013 survey, this region was the one with the highest 
T. gondii seroprevalence (33 %), which was significantly higher (about 2.5 – fold) than the region 
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showing the lowest values (north – 13 %). The variation in the geoseroprevalence of this parasite 
may be due to the local rainy conditions and altitude (Flegr et al., 2014). Nevertheless, this would 
explain the lower values observed for the south region in the first two surveys when compared 
with the other regions, but contradicts the scenario observed in the 2013 survey, as the south of 
Portugal presents a prominent lower altitude and is clearly drier and warmer than the remaining 
regions. 
In most human populations, the T. gondii seroprevalence increases with age, indicating that 
infection is acquired throughout life (Holliman et al., 2003). Our study was no exception and 
showed a higher seroprevalence in older age groups (for all geographical regions), most likely 
due to their longer exposure to the risk factors. 
Concerning childbearing women, we observed a significant decreasing trend in the  
T. gondii seroprevalence over time (Table 2.4). This observation is corroborated by other studies, 
which show that the prevalence of T. gondii infection in women of childbearing ages has 
decreased over the past 30 years (Bobić et al., 2011), and consequently, more women are now 
susceptible to the infection. Besides the factors stated above that most likely justify the 
seroprevalence decrease in the general population, the major factor associated with the decline 
observed for this target group most likely relies on the promotion of educational programmes 
yielding an improvement of the primary prevention. The currently observed seroprevalence of 
18 % indicates that about 80 % of Portuguese women are not immune against the T. gondii 
infection. Thus, the majority of potential pregnant women are susceptible to primary infection 
and the risk of congenital toxoplasmosis is high, a scenario that mirrors the one observed for 
several cities in Spain (Bartolomé Alvarez et al., 2008). The low prevalence observed among 
women of childbearing age should not be neglected. In fact, a recent study from the WHO 
(Torgerson and Mastroiacovo, 2013), which estimated the global burden of congenital 
toxoplasmosis by using a previously described prediction model (Larsen and Lebech, 1994), alerts 
that the global burden of the disease is considerably higher than that suggested by the congenital 
toxoplasmosis data. The incidence of infection is dependent on the general seroprevalence, 
determining the population susceptibility and the frequency of risk factors for toxoplasmosis 
acquisition. Therefore, seroprevalence should be considered the indicator to establish screening 
policies. Regarding this issue, several countries have no surveillance of the infection, whereas 
others focus solely on severe cases and few have surveillance targeted at congenital toxoplasmosis  
(European Food Safety Authority Panel on Biological, 2007). In Portugal, there is a surveillance 
system, which includes both the screening of pregnant women with follow-up during pregnancy 
of those who are not immune, in order to detect seroconversion, and the mandatory laboratory 
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notification of congenital toxoplasmosis cases detected during this process (Ministério da Saúde: 
Direção-Geral da Saúde, 2011). 
This study reinforces that prenatal screening for toxoplasmosis is necessary due to the high 
rate of seronegative women exposed to infection and the probability of a high number of primary 
infections in the childbearing period. Targeted information should be crucially provided to 
childbearing and pregnant women by the health professionals regarding consumption of uncooked 
or cured meat, raw vegetables, contaminated drinking water and contact with cats. With one 
exception (Toxovax for sheep), there is no approved vaccine to prevent human or animal 
toxoplasmosis; therefore, primary prevention is the major tool to prevent the infection in the 
general population, mainly in high-risk individuals, such as immunocompromised, pregnant and 
childbearing women. Besides these primary prevention measures, there are several actions that 
will determine the prevention and control of T. gondii infection, including the governmental 
inspection of slaughterhouses and food production industries, the improvement of hygienic 
standards of abattoirs, the promotion of public educational schemes and the establishment of 
serological screening programmes. 
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3. Genetic and virulence characterization of Toxoplasma gondii isolates 
causing human infection in Portugal 
3.1. Abstract 
Toxoplasma gondii is an apicomplexan parasite responsible for toxoplasmosis which 
infects all warm-blooded vertebrates, including humans, this infection is mostly asymptomatic in 
immunocompetents but in immunocompromised individuals, may lead to death when associated 
with reactivation of cysts both in situations of congenital and acquired infection. The laboratorial 
notification of congenital toxoplasmosis cases is mandatory in our country being the pre and 
postnatal diagnosis of toxoplasmosis carried out in Portugal exclusively at National Institute of 
Health Doctor Ricardo Jorge (NIH). The majority of studies conducted in Europe have revealed 
that more than 80 % of strains isolated from human infections belong to genotype II, whereas 
genotypes I and III are responsible for a small number of cases. Atypical and recombinant strains 
are generally associated with more severe infections. In Portugal, there is a lack of data concerning 
genetic diversity as the classical typing studies in humans have never been performed. We aimed 
to determine the Sag2 and microsatellite-based (TUB2, TgM-A, W35, B17, B18) genotypes of T. 
gondii strains as well as to study their virulence in mice. These strains were isolated from the 
biological samples of the patients with suspected toxoplasmosis whose attented NIH, also we 
estimated the demographic characteristics of the referred patients in the last ten years. We 
analyzed 48 strains from congenital and acquired toxoplasmosis context. Sag2-based genotyping 
of T. gondii was achieved in all 48 strains where 35 (73 %) were classified as type II and 13 (27 
%) were type I. The multilocus PCR of five microsatellites allowed the classification of 10 strains 
(21 %) as recombinant strains that had been previously identified as type II or I by Sag2 typing. 
Seven out of the 48 strains, including three types I, three recombinant, and one type II, were 
virulent in mice. This study constitutes the first evidence of recombinant strains circulating in 
Portugal in humans from congenital infection, highlighting the need for a better evaluation of 
these strains as their phenotype is still barely understood. 
 
Keywords  Toxoplasma gondii, Genotype, Recombinant strain, Congenital toxoplasmosis  
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3.2. Introduction 
The Toxoplasma gondii is an apicomplexan protozoan parasite and one of the most 
successful parasites worldwide due to its ability to infect all warm blooded animals including 
humans. One third of the world’s human population is assumed to be infected with T. gondii 
(Weiss and Dubey, 2009; Innes, 2010). Toxoplasmosis is the infectious disease caused by this 
parasite and is mostly asymptomatic in immunocompetent individuals; however retinitis is often 
a cause of severe eye disease in healthy adults (Gilbert et al., 1999). In immunocompromised 
individuals, the infection may be severe or even lead to death when associated with reactivation 
of cysts in situations of congenital and acquired infection. During pregnancy, this infection can 
cause miscarriage or serious congenital diseases namely encephalitis, chorioretinitis, and 
lymphadenopathy. In the majority of newborns the infection may be asymptomatic; these 
children, when deprived of treatment, may develop recurrent toxoplasmosis which can lead to 
blindness and neurological problems during childhood and adolescence (Zhou et al., 2011), such 
as schizophrenia (Torrey et al., 2012), bipolar disorder (Del Grande et al., 2017), depression and 
attempts to suicide (Groër et al., 2011). In Portugal, there is a guideline for screening of pregnant 
women with follow-up during pregnancy of those who are not immune (Ministério da Saúde: 
Direção-Geral da Saúde, 2011). According to the document of the Ministry of Health, the 
laboratorial notification of congenital toxoplasmosis cases is mandatory (Saúde, 2014) also this 
document establishes that a case of congenital toxoplasmosis is confirmed by the existence of at 
least one of the following four criteria: a) confirmation of the presence of T. gondii in tissues or 
body fluids of the newborn; b) detection of nucleic acids of T. gondii in a biological sample (body 
fluids of the newborn); c) antibody specific response to T. gondii (Ig M, IgG and IgA) in a 
newborn; d) serum stable titers of T. gondii IgG every two months in children less than twelve 
months old. The first line of diagnosis of an infection acquired during pregnancy is the serology. 
Then, for the suspected cases, mice inoculation and PCR are performed in the amniotic fluid (AF) 
finally, after baby's birth the later two procedures are also applied to placenta (PL) and newborn 
blood (NBB). Thereby the whole pre and postnatal diagnosis of toxoplasmosis is composed by 
serological, molecular and mice inoculation approaches and is carried out in Portugal exclusively 
at National Institute of Health Doctor Ricardo Jorge (NIH), where we have a collection of 
biological products and strains that likely constitutes a national representation of this infection. 
Thus, the biological products from all over the country are routinely sent to NIH laboratory to 
confirm the presence of this parasite as well as to perform the molecular characterization of the 
isolates. It is believed that the number and the genetic diversity of parasites that are causing the 
infection play an important role in pathogenesis of T. gondii (Sarvi, 2019). Although the 
determinants of disease severity are not well understood, several factors such as host genotype, 
nutrition, immune status, infection load, and parasite genotype have been suggested to influence 
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the outcome of infection (Sibley et al., 2002). The distribution of T. gondii genotypes varies by 
geographic region (Lehmann et al., 2006). Genetic studies of isolates from Europe and the United 
States, suggested the presence of a clonal population structure stable in time and space (Darde et 
al., 1988; Sibley and Boothroyd, 1992; Dardé et al., 1992; Howe and Sibley, 1995; Ajzenberg et 
al., 2002a). The majority of the isolates (> 94 %) are linked into the three main clonal multilocus 
genotypes I, II and III, where the population structure of T. gondii in Europe (De Sousa et al., 
2006; Jokelainen et al., 2012) belongs predominantly to the type II lineage. In the south of Europe 
(Mediterranean countries), genetic diversity seems to be higher, revealing genotypes I and III and 
recombinant (Messaritakis et al., 2008; Mancianti et al., 2014; Vilares et al., 2014; Bacci et al., 
2015). A fourth clonal lineage (haplotype 4) has been described as the most common type in 
wildlife in North America (Dubey et al., 2011; Rajendran et al., 2012). These findings are based, 
not only on the classical typing procedures (Sag2 and microsatellite typing), but also on PCR-
RFLP by using other loci (Waap et al., 2008; Jokelainen et al., 2012; Vilares et al., 2014; Verma 
et al., 2015). In both animal and human samples, atypical and recombinant strains have been 
rarely reported (Bossi and Bricaire, 2004; Ajzenberg et al., 2004; Lehmann et al., 2006; 
Cavalcante et al., 2007; Vilares et al., 2014). Several studies revealed that recombinant (Dubey 
et al., 2007a; b) and atypical strains are associated with more severe symptoms in 
immunocompromised hosts, the atypical genotypes are frequently associated with severe 
toxoplasmosis also in the immunocompetent human patients (Grigg et al., 2001a; Bossi and 
Bricaire, 2004; Carme et al., 2011; Demar et al., 2012). In Portugal, there is a lack of data 
regarding the T. gondii genotype distribution in humans, and this issue gains special relevance 
since Portugal has a long history of trade and social interaction with Brazil and African countries, 
involving human and animal migrations and also import/export of food products. In fact, only one 
study has been published involving human samples (Sousa et al., 2008), but it was based on 
serotyping (antibodies anti-GRA6) rather than on molecular approaches. That study revealed a 
majority of type II strains but also an unexpected high prevalence of non-type II strains that could 
not be typed as type I or III, suggestive of a recombinant profile. The existence of recombinant 
strains was later reported in animals (Vilares et al., 2014). These results suggested the existence 
of a typing profile different from the one found in the other European countries (Sousa et al., 
2008). Considering this, our study aims to evaluate the T. gondii genotyping distribution and the 
virulence in mice of strains isolated from the biological samples of the patients with suspected 
toxoplasmosis. Also we describe the demographic characteristics of the referred patients, whose 
laboratory diagnosis was confirmed in the National Reference Laboratory of Parasitic and Fungal 
Infections of the NIH.   
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3.3. Materials and methods 
Sample  
We performed a retrospective analysis of the laboratory results of all cases with clinical 
suspicion of congenital and acquired toxoplasmosis, which have recourse to NIH for confirmation 
of infection, between January 2009 until December 2018. A total of 5722 cases were analysed 
(see Results for details) and we proceeded to study the molecular and virulence characteriza t ion 
of the strains isolated from the several biological samples of the positive cases. 
For the descriptive analysis of the demographic data of the confirmed cases we used the 
calculation of absolute and relative frequencies. 
 
Human biological products  
Different biological products, namely blood (mother and child), amniotic fluid and placenta 
were analysed for the laboratory confirmation of congenital infection (pre and postnatal). For the 
laboratory diagnosis of acquired infection were analysed cerebrospinal fluid (CSF), cerebral 
biopsy (CB), vitreous humor (VH) and aqueous humor (AH). 
 
T. gondii isolates  
All strains belong to the strain collection of the National Reference Laboratory of Parasitic 
and Fungal Infections at the Portuguese National Institute of Health (NIH) which is the 
responsible laboratory in Portugal for the pre - and postnatal diagnosis of toxoplasmosis at 
national level. We studied 48 T. gondii strains being 47 isolated in a congenital toxoplasmosis 
context from the follow biological samples: 31 strains were isolated from placentas (PL), 9 from 
umbilical cords blood (UCB), 5 from amniotic fluids (AF) and 2 from new born blood (NBB). In 
scope of aquireded toxoplasmosis, a single strain was isolated from a cerebral biopsy (CB) of a 
positive HIV with cerebral toxoplasmosis. The 48 strains revealed the following geographic 
distribution: 66.7 % were collected from the central region of Portugal, 25 % from the north,  
6.3 % from the south, and 2 % from the Azores islands. 
 
Laboratory confirmation  
For the laboratory confirmation of congenital infection (pre and postnatal) we performed: 
Serological methods such as  Direct Agglutination test (DAT) (bioMérieux SA, Marcy-l’Étoile, 
France), Enzyme-Linked Fluorescent Assay (ELFA), bioMérieux SA, Marcy-l’Étoile, France), 
Immunoglobulin Immunosorbent Agglutination Assay (ISAGA) (bioMérieux SA, Marcy-
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l’Étoile, France), and Imunoblot (IB) (LDBIO Diagnostics, Lyon, France); molecular methods 
(real-time PCR for amplification of the REP-529bp repeat region) (Kasper et al., 2009) and mice 
inoculation. 
 
Mice Inoculation  
The inoculation, maintenance, and euthanasia of mice were performed according to the 
Portuguese standards of the NIH, established for the pre- and postnatal diagnosis of 
toxoplasmosis, which are in accordance with the Protocol of International Guiding Principles for 
Biomedical Research Involving Animals as issued by the Council for the International 
Organizations of Medical Sciences. Briefly, all clinical samples were inoculated by 
intraperitoneal injection (1 ml/mouse) in female mice [Hsd: ICR (CD-1®); Harlan Ibérica, 
Barcelona], two each for the AF, BB, UCB, and CB, and four for PL samples with negative 
serology to endoparasites. AF were centrifuged and resuspended in 1 ml, and PL were pretreated 
with trypsin (1:250) and antibiotics (250 UI / ml penicillin and 500 μg / ml streptomycin) before 
the inoculation. The remaining biological samples were not subjected to any pretreatment 
protocol.  
The inoculated animals were monitored serologically by DAT at 10, 21, and 42 days post-
inoculation (p.i.), in order to check the presence of T. gondii-specific antibodies. At the end of 
this period, mice were euthanized by inhalation of 5 % halothane and confirmed death by physical 
examination. The general morphological state of organs was observed, and sample tissues were 
collected from the brain and were visualized by optical microscopy in order to search for T. gondii 
cysts.  
Although tissue cysts may develop in visceral organs, including the lungs, liver, and 
kidneys, they are more prevalent in the neural tissues, including the brain (Suzuki et al., 2010). 
Intact tissue cysts are believed not to cause any harm and can persist for the life of the 
immunocompetent host without causing a host inflammatory response (Dubey et al., 1998). We 
defined virulence at isolation (without knowledge of infecting dose) based on the mortality of 
mice within 4 months of infection and categorized isolates into two groups: virulent (death of  
100 % of mice) and nonvirulent (< 30 % death). 
 
T. gondii DNA extraction 
T. gondii DNA was extracted from two different mice samples, namely, the ascitic fluid or 
the brain, depending on the concentration of tachyzoites in microscopy of ascetic fluids. The   
T. gondii DNA extraction from ascitic fluids was performed by boiling 1 ml of the sample for  
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30 min. From tissue cysts (± 1 cm3), DNA was extracted by using the QIAamp DNA mini kit 
(Qiagen, Chatsworth, USA) according to the manufacturer’s tissue protocol, with slight 
modifications. These consisted of the homogenization of samples with 200 μl of extraction buffer 
and 40 μl of proteinase K and the DNA elution with 50 μl of elution buffer. 
 
Genotype analysis of T. gondii 
For genotyping purposes, all DNA samples from the inoculated mice were subjected to 
amplification and sequencing of the two ends of Sag2 gene and to a multiplex PCR of five 
microsatellites. The later included the beta-tubulin (TUB2) and the myosin A (TgM-A) genes as 
well as three expressed sequence tag (W35, B17, B18) markers (Howe et al. 1997; Ajzenberg et 
al. 2002, 2004). For Sag2, the PCR products were visualized in GelRED (Biotium Inc., Fremont, 
USA) stained 2 % agars gel electrophoresis, purified, and sequenced with an ABI 3130xl Genetic 
Analyzer (Applied Biosystems). For microsatellite analysis, capillary electrophoresis of PCR 
products was performed on the ABI 3130xl Genetic Analyzer (Applied Biosystems), and data 
were stored and analyzed with Gene Mapper (version 3.7; Applied Biosystems). MEGA5 
software (Tamura et al., 2007) was used to identify the genotypes by comparing the obtained 
sequences with the ones from reference strains available in GenBank (ME49-XM_018781602.1, 
VEG-LN714498.1, and RH-AY941252.1 and AY895019.1, RUB-AF357581.1, and MAS-
AF357580.1). 
 
3.4. Results 
Sample characterization 
During the ten years study period, 1459 cases of suspected toxoplasmosis were confirmed 
in a total of 5722 analyzed. Of these, 1436 (98.4 %) were patients with acquired infection and 23 
(1.6 %) were patients with congenital infection (Figure 3.1). 
Concerning the acquired infection, 93.4 % (1341/1436) were females, 5.5 % (79/1436) 
males and in 1.1 % (16/1436) of cases the gender was not known (Figure 3.2).  
Regarding the distribution of cases of acquired infection by age group, it was observed that 
the majority of the women belonged to the group 25-44 years old 75.8 % (588/1341), followed 
by the group aged 15 - 24 years 16.9 %, (226/1341), with the majority of men belonging to the 
age group between 25 and 64 years old. Of the 23 cases of confirmed congenital toxoplasmosis 
during the 10 years under analysis it was found that 22 were children under one year of age and 
one were a child belonging to 1- 4 years old (Table 3.1). The frequency of cases of congenital 
infection all over these ten years of study was 1.6 %, (23/1459). 
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Figure 3.1. Annual distribution of acquired and congenital Toxoplasma gondii infection, 2009-2018. 
Number of cases by year of diagnosis. 
 
 
 
Figure 3.2 Annual distribution of Toxoplasma gondii infection acquired by gender, 2009-2018. 
Number of cases by year of diagnosis.  
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Table 3.1. Annual distribution of acquired and congenital Toxoplasma gondii infection by age group,  
2009-2018. Number of cases by year of diagnosis . 
 
Age 
(years) 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Total 
< 1 1 4 3 4 2 0 3 0 3 2 22 
1 – 4 0 0 0 0 0 0 0 0 1 0 1 
5 – 14 4 0 0 0 0 2 3 1 0 2 12 
15 – 
24 
32 41 25 19 21 18 23 26 16 19 240 
25 – 
44 
66 106 115 75 88 124 147 112 140 80 1053 
45 – 
64 
1 0 9 7 3 6 4 2 6 2 40 
> 64 1 0 4 3 0 0 0 0 1 3 12 
AU 21 0 16 0 24 2 0 1 5 10 79 
Total 126 151 172 108 138 152 180 142 172 118 1459 
 
 
Analysis of virulence in mice  
Seven (Str_1, Str_3, Str_6, Str_11, Str_13, Str_18, Str_28) out of the 48 strains showed to 
be virulent in mice (Table 3.2), as they killed the mice after the first inoculation. Considering the 
location of tissue cysts, we searched for the presence of cysts in mice brain and found that, except 
for ten cases, all were positive. Two of the strains (Str_11, Str_3) that did not yield cysts in mice 
brain were virulent in mice. In this work, we did not observe moderate virulence (30% to less 
than 100 % mortality). 
 
Genotype analysis 
Sag2 genotyping was achieved in 100 % of samples and allowed the differentiation among 
the three “classical” T. gondii strain types. Thirty-five (73 %) strains were classified as type II, 
where 23 were isolated from mice inoculated with PL, four with AF, two with BB, and six with 
UCB. Thirteen (27 %) belonged to type I, where eight strains were isolated from mice inoculated 
with PL, one with AF, one with CB, and three with UCB (Table 3.2). PCR multiplex 
microsatellites analysis was applied to all samples and was highly efficient, it allowed the 
identification of 35 (73 %) strains as type II (25 PL, 3 AF, 1 BB, and 6 UCB), six (12.5 %) as 
type I (1 PL, 1 AF, 1 CB, and 3 UCB), one (2 %) as type III (1 PL), and six (12.5 %) as 
recombinant strains (4 PL, 1 AF, and 1 BB). Ten strains (21 %) identified by microsatellites 
analysis did not confirm the type previously identified by Sag2 typing. In fact, from these 10 
samples, three were identified as type II (previously classified as type I by Sag2), one as type III 
(previously classified as type I by Sag2), three as I/III recombinant strains (previously classified 
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as type I by Sag2), and three more as I/II recombinant strains (previously classified as type II by 
Sag2) (Table 3.2).  
Except one because we have no data, all the virulent strains were isolated in biological 
samples whose the newborns showed positive serology for IgG and IgM. Regarding PCR findings 
was negative or we had no data. Concerning newborn clinical features and treatment there is a 
lack of information from the clinicians to the laboratory (Table 3.2). 
 
Table 3.2. Virulence and genotyping analysis of Toxoplasma gondii strains and laboratorial and clinical 
features of the biological samples . 
 
Strain 
Number 
Biological 
sample 
Mice virulence 
/death day after 
inoculation 
Genotype 
NB 
Serology 
IgG/IgM 
NBB 
PCR 
NB 
clinical 
features 
Treatment 
1 AF V/9 I +/+ nd - - 
2 UCB NV I +/- - - - 
3 UCB V/9 I +/+ I - - 
4 AF NV II nd nd - - 
5 AF NV II +/+ - - - 
6 PL V/11 I nd nd - - 
7 PL NV II +/+ - - - 
8 PL NV II +/+ nd - - 
9 PL NV REC I/II +/+ - - - 
10 PL NV REC I/III +/- - - - 
11 PL V/7 REC I/III +/+ - - - 
12 PL NV II +/+ nd - - 
13 PL V/42 REC I/III +/+ - - Rov 
14 PL NV II +/- + - - 
15 UCB NV II +/- - - - 
16 PL NV II +/+ - - - 
17 PL NV REC I/II nd + - - 
18 PL V/120 II +/+ - - - 
19 UCB NV II nd - - - 
20 PL NV II +/+ - - Spir 
21 UCB NV II +/+ I - - 
22 PL NV II +/- I - Spir 
23 PL NV II +/+ nd - Rov 
24 UCB NV II +/+ - - No 
25 PL NV REC I/II +/+ I IC Rov 
26 PL NV II +/+ nd - Spir 
27 AF NV REC I/II Nd I - Spir 
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28 PL V/10 REC I/II +/+ nd - Rov 
29 PL NV II nd nd - - 
30 AF NV II +/- + - Sulf+Pyr 
31 CB NV I NA NA NA NA 
32 PL NV II +/+ - - No 
33 UCB NV II +/- - -  
34 UCB NV I +/+ + - - 
35 PL NV II nd nd IC+C No 
36 UCB NV II   IGR - 
37 PL NV II +/- - - - 
38 PL NV II +/+ + - Rov 
39 PL NV II +/- - - Spir 
40 PL NV II +/- - - - 
41 PL NV II nd - - No 
42 NBB NV REC I/II +/- + - - 
43 PL NV 
REC I/II 
or II/III 
+/- - - - 
44 PL NV II +/- nd - - 
45 PL NV II nd - - - 
46 PL NV II +/+ - - Spir 
47 PL NV II nd nd H Rov 
48 NBB NV II +/- - - Spir 
        
AF amniotic fluid, UCB umbilical cordon blood, PL placenta, CB cerebral biopsy, NB newborn, NBB newborn blood, 
NV nonvirulent, V virulent, REC recombinant , Sulfadiazine (Sulf) and pyrimethamine (Pyr), Spiramycin (Spir), 
Rovamycin (Rov), Not applicable (NA), Intracranial calcifications (IC), Chorioretinitis (C), Intrauterine growth 
retardation (IGR), hydrocephalus (H) No data (nd), Inhibition (I) Positive (+) and (-) Negative. 
 
 
3.5. Discussion  
According to the laboratory criteria applied to the diagnosis of congenital toxoplasmosis, 
the 23 cases of infection in this study obtained a positive result for IgG and IgM antibodies, 
molecular detection and mice inoculation, leading to their validation as congenital toxoplasmosis 
cases.  
As in other European countries, this study showed that that the greatest number of cases 
occurred in the 25 - 44 years of age and predominantly in women, what is expected because 
Portugal is one of the countries of the European Union where it is recommended to carry out the 
laboratory diagnosis of toxoplasmosis to all pregnant women and childbearing women who want 
to get pregnant (Ministério da Saúde: Direção-Geral da Saúde, 2011). With the exception of 
France, Germany and Poland that showed highest rates of new cases the new cases rates of 
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congenital toxoplasmosis found in this study is similar to the ones observed in the remain 
European coutries that range 0-4 cases per year (ECDC, 2017). In spite of the frequency of cases 
of congenital infection is low all over these ten years of study (1.6 %, 23/1459), it is important to 
emphasize that the majority of the acquired infections occurred in pregnant women, subsequently 
may have originated congenital infections. This fact demonstrates, for itself, the importance of 
laboratory toxoplasmosis surveillance in the pre-conception period and, even more, during 
pregnancy. According to the national seroprevalence study (corresponding to the study presented 
in Chapter II) (Gargaté et al., 2016) the 18% of seroprevalence in childbearing women indicates 
that about 80% of portuguese women are not immune against the T. gondii infection. Thus, the 
majority of potential pregnant women are susceptible to primary infection and the risk of 
congenital toxoplasmosis is high. Thus, the identification of cases of toxoplasmosis in the present 
study corroborates the results referenced in previous studies and demonstrates the importance of 
active surveillance and systematic diagnosis of this infection, particularly in pregnant women and 
immunocompromised individuals, because they are population groups where this parasite is 
responsible for high morbidity and lethality rates.  
In Portugal, as in most European countries, T. gondii isolates collected from animals (which 
enroll the majority of the studies) with chronic infections have shown remarkably little genetic 
diversity, where type I or recombinant strains have been rarely found (Herrmann et al., 2010, 
2013; Herrmann, 2012; Vilares et al., 2014). Concerning strains collected from human beings, 
type II predominates in Europe (Howe et al., 1997; Ajzenberg et al., 2005), mirroring the scenario 
found in animals. However, there is a lack of knowledge of the genetic diversity of 
T. gondii strains from human samples in Portugal. The only previously published data concerns 
the report of type II strains in two HIV seropositive individuals (Ajzenberg et al., 2009). In the 
present study, we enrolled 48 T. gondii strains collected throughout about two decades and 
observed that 67 % (32/48) of strains were classified as type II simultaneously by Sag2 and 
microsatellite procedures, which was quite similar to the genotypes distribution found in other 
European and US studies (Herrmann et al., 2014). The results of multilocus genotyping were in 
agreement with the Sag2 genotyping for 38/48 isolates. The ten discrepant strains reinforce the 
interest of using a multilocus approach. Particularly, seven Sag2 type I isolates exhibited a 
mixture of type I/III or I/II alleles and three type II isolates exhibited a mixture of type I/II, being 
considered as recombinant strains. In this regard, the microsatellite typing method, which uses 
one multiplex PCR to perform multilocus typing with five markers (Ajzenberg et al., 2005), was 
an efficient and essential tool for the identification of a molecular epidemiology scenario where 
21 % (10/48) of the investigated strains were found to be recombinant strains. These were 
described in Portugal for the first time in 2008 and also in 2014 (both in animals) (Waap et al., 
2008; Vilares et al., 2014). We speculate that the higher proportion of type I and recombinant 
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isolates in the human Portuguese sampling compared to other European studies (Howe et al., 
1997; Nowakowska et al., 2006a; Ajzenberg et al., 2010) may be explained by the fact that 
Portugal has a long history of trade and social interaction with South American countries (such 
as Brazil) and China (where atypical and recombinant strains are not uncommon), which involve 
human migrations, the import of food products (like meat or vegetables with the potential of 
transmitting the parasite), and also the presence of rats and cats (T. gondii intermediate and 
definitive hosts, respectively) in trading ships. Concerning the inoculation in mice, the virulence 
rate in vivo was quite low, 15 % (7/48), which is similar to the one observed in other countries 
(Ajzenberg et al., 2002a; Gebremedhin et al., 2014a). Two recombinant type I/III (Str_11, Str_13) 
and one recombinant type I/II (Str_28) were lethal to mice at the first inoculation and two of these 
(Str_11, Str_28) had the ability of transplacental transmission to the fetus. Unexpectedly, two 
type I strains were not lethal to mice, and mice death inoculated with one type II strain was 
observed. One could speculate that these strains may not be typical type I and II strains but instead 
recombinant strains that could not be identified with the limited number of molecular markers 
used. Another explanation for the observed virulence of the type II strain could be an elevated 
parasite load in the inocula. In fact, the biological samples are inoculated in mice according to the 
standard clinic diagnostic procedures, preventing the a priori determination of the number of 
parasites. 
As concluding remarks, this study presents the first data in Portugal concerning T. gondii 
genotyping from human samples and it reveals genetic variations in the predominant clonal 
lineages and more specifically the existence of a considerable proportion of recombinant strains. 
It is imperative to better characterize the genetic background of these unusual strains as unusual 
genotype-phenotype associations (e.g., implications in specific disease outcomes) may eventually 
be found for some recombinant profiles. In this regard, it will be important to strength the genetic 
characterization of T. gondii strains by analyzing several other loci that are polymorphic and 
genome dispersed, in order to better understand the degree of genomic mosaicism displayed by 
the circulating strains. 
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4. Parallel propagation of Toxoplasma gondii in vivo, in vitro and 
alternate models: towards less dependence on the mice model 
4.1. Abstract 
Toxoplasma gondii is an obligate intracellular protozoan able to infect most mammals 
worldwide. In pregnant women it can lead to severe birth defects or intrauterine death of the fetus. 
In immunocompromised patients, reactivation of latent infection may lead to life-threatening 
encephalitis. Almost everything we currently know about cell biology, immunology and genetics 
of T. gondii was achieved by using the RH virulent strain propagated in mice, as a model in the 
majority of the national reference laboratories for toxoplasmosis. According to the new 
recommendations concerning the animal welfare on behalf of their use in laboratory, we aimed to 
evaluate the potential of an in vitro system based on T. gondii propagation in cell-line, to replace, 
or at least reduce, the demanding animal model for strain propagation. 
We evaluated the genetic and phenotypic stability of the T. gondii RH strain throughout its 
parallel continuous propagation in mice, in human foreskin fibroblasts, and in an alternate fashion 
of these two procedures. We also assessed the virulence impact of RH strain after different periods 
of long-term propagation strictly in cells.  
Concerning the phenotypic impact of long-term tachyzoite passage in HFF we observed 
that the RH strain completely lost its virulence. On the other hand, we obtained a successful 
outcome with the alternate passaging of the parasite in HFF and in mice as this approach enabled 
T. gondii to maintain the virulence potential while keeping a putative stable genome. Although 
this strategy was very encouraging and putatively allows the reduction of sacrificed mice in more 
than 80 %, future studies are needed to evaluate its applicability to clinical strains, which are 
typically less virulent than the reference RH strain. 
 
Keywords: genetic stability . phenotypic stability . RH strain . mice inoculation . Tachizoites 
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4.2. Introduction 
Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan able to infect most 
mammals worldwide. The parasite exists in three stages: i) oocysts, the product of sexual 
recombination in the intestine of members of the feline family; ii) tachyzoites, the invasive, 
rapidly replicating intracellular stage of the parasite; and iii) bradyzoites, the slowly replicating 
stages found in cysts in latently infected hosts (Holliman et al., 2003). T. gondii infects up to a 
third of the world's human population and infection is mainly acquired by ingestion of food or 
water that is contaminated with oocysts shed by cats, or by eating undercooked or raw meat 
containing tissue cysts (Weiss and Dubey, 2009). This parasite crosses the intestinal, the placenta 
and the blood–brain barriers, and persists in its latent form in the central nervous system and 
muscle tissue. Primary infection is usually subclinical but in some patients it varies from a flu-
like syndrome to lymphadenopathy and retinochoroiditis; infection is mostly asymptomatic in 
pregnant women but can lead to severe birth defects or intrauterine death in the fetus. In 
immunocompromised patients, namely AIDS and organ transplantation patients, reactivation of 
latent infection may lead to life-threatening encephalitis (Weiss and Dubey, 2009). 
Almost everything we currently know about cell biology, immunology and genetics of  
T. gondii has been discovered using the RH strain as a model, which is a strain that was isolated 
in the USA by Albert Sabin from a 6-year-old boy who died of encephalitis in 1939 (Sabin, 1941).  
Strain genotyping revealed that more than 95 % of strains belonged to one of three major 
clonal lineages, known as types I, II and III which predominate in North America and Europe 
(Howe and Sibley, 1995). More recent genetic analyses identified a fourth lineage in North 
America (Khan et al., 2011). The RH strain and most of other highly virulent strains for mice 
were classified into lineage I, whereas the non-virulent strains mostly clustered into lineages II or 
III. The three lineages are all genetically identical, differing only by approximately 1–2% at the 
nucleotide level (Sibley et al., 2009). Still, despite their expectedly high genetic similarity, they 
can induce strong phenotypic differences in mice. Type I (high virulence) strains are mortal at all 
doses, are more motile than the less virulent strains and are able to migrate across cellular barriers, 
which may explain how they disseminate so rapidly in vivo and cause high mortality (Barragan 
and Sibley, 2002), whereas types II (intermediate virulence) and III (low virulence) strains are 
much less pathogenic(Sibley and Boothroyd, 1992).  
Population genetics and epidemiological studies have indicated a correlation between the 
geographic variations of this parasite genotype and disease manifestation in humans. For example, 
severe symptoms associated with ocular toxoplasmosis are more frequently reported in Brazil 
than in European countries (Grigg et al., 2001a; Holland, 2003), and numerous incidences of 
severe systemic toxoplasmosis in immunocompetent adults from French Guiana have been 
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reported, in some cases resulting in the deaths of the afflicted individuals (Ajzenberg et al., 2009); 
Darde et al., 1998; (Demar et al., 2012). Taken together, virulence of different T. gondii strains 
in mice appears to be generally correlated with disease manifestations in human cases (Yolken, 
2015). Therefore, determination of T. gondii virulence in mice could be invaluable in predicting 
the potential outcome of human infections. 
The legislative regulations introduced in the last years by several countries had a huge 
impact on the development and evolution of the laboratory animal manipulation. The book of 
Russell and Burch of 1959, entitled The Principles of Humane Experimental Technique, became 
a central theme in laboratory animal science because it highlights how animal experimentation 
can be diminished or removed (Russell and Burch, 1959). These authors introduced the Three Rs 
concept, designating the terms Reduction (i.e., decrease the number of animals used), Refinement 
(i.e., diminish in the incidence or severity of painful or distressing procedures) and Replacement 
(i.e., substitution of living animals by in vitro techniques, computerized models, etc.), as a main 
guideline for the responsible use of animals in experiments. This concept is particularly applicable 
to T. gondii given the very high number of mice used in reference laboratories for strain 
maintenance and diagnosis. According to the new recommendations concerning the animal 
welfare on behalf of their use in laboratory, we aimed to evaluate the potential of an in vitro 
system based on T. gondii propagation in cell-line, to replace, or at least reduce, the demanding 
animal model for strain propagation. To reach this goal, we evaluated the genetic and phenotypic 
stability of the virulent T. gondii RH strain throughout its parallel propagation in mice, in human 
foreskin fibroblasts, and in an alternate fashion of these two procedures. 
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4.3. Material and Methods 
The RH strain used in the present study is routinely maintained in mice by syringe 
intraperitoneal inoculation passages of ascitic fluid at 2-day intervals at the National Reference 
Laboratory of Parasitic and Fungal infections from the National Institute of Health since 1985. 
 
General Workflow 
We prepared six suspensions of the RH strain obtained from the mice ascitic liquid  
(Figure 1), each containing about 1×105 of tachyzoites in 0.2 ml. The concentration of tachyzoites 
was determined by using a Neubauer chamber under light microscope (40 x magnification) and 
its viability was accessed after staining a cover slip with metilen blue at  
0.1 % (v/v). These suspensions were used to simultaneously inoculate in two mice (“experiment 
A”), in two cell culture flasks (“experiment B”) and in two additional cell culture flasks 
(“experiment C”). As represented in Figure 1, the experiment A consisted of continuous passages 
of the RH strain in mice, the experiment B consisted of continuous passages of the RH strain in a 
cell line, and finally, the experiment C consisted of intercalate passages of the RH strain in the 
cell line and in mice. This study was developed during a period of 10 months. At the harvesting 
steps (detailed below), a 500 µl aliquot was taken and frozen at – 20 ºC and – 80 ºC. From this 
large set, 30 samples (10 samples from each experiment A, B, and C), corresponding to one sample 
per month, were subjected to genetic characterization of the passages strain by Next Generation 
Sequencing (NGS) (also detailed below). Additionally, two control mice were injected with 
DMEM only and two cells culture flasks were used as control as well. 
In order to set up the time points enrolled in Experiment C (i.e., the decision of a suitable 
period regarding the maintenance of the tachyzoites in cells before passing them to mice), we 
preliminarily evaluated the time at which the tachyzoites revealed a considerable number and 
motility decrease and shape alteration (through microscopic evaluation). This time consisted of 
approximately three weeks (data not shown), so we opted for a highly conservative approach in 
Experiment C by designing it with periods of RH passaging in the cell line not exceeding one 
week. Concerning experiment B, which is a challenging mice-independent procedure, to avoid 
the culture loss, whenever a strong decrease on the number of harvested tachyzoites was observed 
(after approximately 12 days), the aliquot of the immediate previous passage was thawed and was 
used to proceed the continuous cell line culture.  
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Figure 4.1 Workflow of RH strain inoculations. Experiment A: continuous mice inoculation, which took 
place every two days; Experiment B: continuous cell line (Human foreskin fibroblasts) passages, taking 
place every 72 - 96 h; Experiment C: intercalate cell line passages and mice inoculation. Before each 
inoculation in mice, tachyzoites were propagated for two periods of 72 - 96 h (designated as “week” in the 
Figure) in the cell line. The study duration was about 44 weeks (about 10 months).  
* Although the experiment B consisted of a continuous passaging of the RH strain exclusively in the cell 
line, an aliquot taken from the harvesting procedure at week 3, 22 and 44 was used for a mice inoculation 
in order to evaluate the phenotypic impact after different periods of long -term propagation of T. gondii 
strictly in cells. 
 
 
Mice propagation 
We used female CD1 mice with 6-8 weeks old and weighted 16 - 18 grams [Hsd: ICR (CD-
1®); Harlan Ibérica, Barcelona]. Mice inoculation, maintenance and euthanasia were performed 
under the standards of the Portuguese NIH, which are in accordance with the Protocol of 
International Guiding Principles for Biomedical Research Involving Animals as issued by the 
Council for the International Organizations of Medical Sciences. Animals were housed in cages 
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and maintained under controlled conditions (21 ± 2 °C, 65 - 70 % humidity) and standard food 
and water ad libitum during the experiments. 
A suspension of the RH strain (0.2 ml, corresponding to 1×105 tachyzoites) was inoculated 
in mice by syringe intraperitoneal inoculation and after 48 hours mice were euthanized. Then, 
tachyzoites were harvested from the peritoneal cavity of infected mice by flushing with 5 ml of 
sterile phosphate buffer saline (PBS; 0.01 M, pH 7.2), and were centrifuged at 2000 rpm for 10 
min at room temperature to remove peritoneal cells and cellular debris. The pellets enriched with 
tachyzoites were recovered with PBS (PBS; 0.01 M, pH 7.2) and 0.2 ml of a 1×105 / ml suspension 
were intraperitoneally inoculated in another animal. Following this procedure, brain tissue was 
harvest from the mouse and observed in the light microscope in order to search for T. gondii cysts. 
Visual inspection was used to identify the phenotypic effect of T. gondii RH strain in mice, 
namely, the general condition of the animal, hair condition and stool consistency. This entire 
procedure was rigorously followed in experiment A, and, with exception of the timelines, also 
followed in experiment C for mice inoculation and harvesting. 
 
Cell culture propagation 
Human foreskin fibroblasts (HFF-1ATCC - SCRC-1041) obtained from ATCC were grown 
in 10 ml of culture medium using 25cm2 flasks (Sarstedt, 831810.002). For maintenance purposes, 
this cell line was grown in Dulbecco's Modified Eagle Medium DMEM (Gibco 42430-25) with 
10 % of heat inactivated fetal calf serum FCS (Gibco, 10270106), penicillin (12 ug/ml), 
streptomycin (10 ug / ml) (Gibco 15140 - 122) and (1 %) fungizone (Gibco 15290-018) and was 
incubated in 5 % CO2 at 37 °C and > 80 % humidity. Then, when a confluent monolayer was 
obtained, a maintenance medium (the same as above but supplemented with FCS 5 % instead of 
10 %) was used. Cells were routinely subcultured every 3 days by trypsination, 0.25 % trypsin 
(Gibco 25300 - 062) with 0.03 % EDTA solution and washing with phosphate-buffered saline (pH 
= 7.2).  
For the inoculation with the RH strain, after 70 % confluency of the cell line, 1ml of the 
suspension of tachyzoites (~ 1 × 105) were added to the cell line followed by an incubation at  
37 °C, > 80 % humidity and 5 % CO2 for 72 - 96 h. Two 25 cm2 flasks were always simultaneously 
inoculated. After this period, the medium was aspirated and the cells monolayer was washed with 
5 ml of sterile phosphate buffer saline (PBS; 0.01 M, pH 7.2) and scraped. The amount and the 
viability of tachyzoites harvest from the cell culture were determinate with a Neubauer chamber 
under light microscope (40 x magnification) after staining with metilen blue 0.1 %. These 
tachyzoites were then diluted to a final concentration of 1x105 per ml and constitute the new 
inoculum for a new set of two 25 cm2 flask with 70 % confluency of HFF cells. From each passage, 
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a 500 ul aliquot was taken and freezed with 1ml of 50 % FBS and 1 ml of 20 % DMSO in cryovials 
with a cooling rate of 1 ºC per minute until reaching - 80 ºC and then they were placed in a - 80 
ºC freezer or in a liquid nitrogen tank. Whenever the need to use a frozen aliquot arose (see 
“general workflow” above), the frozen aliquot to be used for inoculation purposes, were placed 
in a water bath at 37 ºC with shaking, until completely thawed. In order to identify the phenotypic 
effect of the T. gondii RH strain on the inoculated cells, direct examination with a phase contrast 
optics microscope (40 x) was used. This entire procedure was rigorously followed in experiment 
B, and, with exception of the timelines, also followed in experiment C for cells inoculation and 
harvesting. 
Although the experiment B consisted of a continuous passaging of the RH strain 
exclusively in the cell line, an aliquot taken from the harvesting procedure at week 3, 22 and 44 
was used for a parallel mice inoculation in order to evaluate the phenotypic impact after different 
periods of long-term propagation of T. gondii strictly in cells. 
 
DNA extraction, PCR and Next Generation Sequencing (NGS) of RH T. gondii strain  
RH T. gondii DNA was extract directly from the ascitic fluid of tachyzoites suspension and 
from the tachyzoites harvest from HFF cells suspension by using the QIAamp DNA mini kit for 
tissues (Qiagen, Chatsworth, USA) according to the manufacturer’s tissue protocol. 
In order to perform a brief evaluation of the genetic stability of T. gondii on the course of 
the three described experiments, the following loci, which are spread by different T. gondii 
chromosomes (http://toxomap.wustl.edu/verticalmap08_01-2005high.jpg), were enrolled in this 
study: i) Sag2 (the classical typing gene); ii) three loci traditionally used for microsatellites-based 
typing (TgM-A, B18, W35); and, iii) five polymorphic loci potentially involved in 
adaptation/virulence (CB21-4, PK1, Gra6, Sag3, M102). Target regions and PCR primers for all 
loci are described in Table 4.1, and are divided in two panels (with and without 5’ adapters for 
amplicon-based NGS Illumina protocols), according to the amplicon size and the position of the 
target microsatellites within some amplicons. In order to generate high quality amplicons for 
subsequent high-throughput amplicon-based Next Generation Sequencing (NGS), different PCR 
were conducted. Briefly, a multiplex PCR was applied for loci M102, B18 and W35, while Sag2, 
TgM-A, CB21-4, PK1, Gra6, Sag3 were targeted by independent PCR. All PCR products were 
visualized in GelRED (Biotarget, Lisbon, Portugal) stained 2% agarose gel electrophoresis. For 
each sample selected for NGS (see above), PCR products, with and without Illumina adapters, 
were pooled separately, before being purified and  and subjected to the Nextera XT DNA Library 
Preparation protocol (Illumina Inc, San Diego, CA, USA), according to manufacturer’s 
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instructions. Finally, libraries obtained from amplicons with and without Illumina adapters were 
independently sequenced (2 x 150bp paired-end reads) using a MiSeq (Illumina) equipment.  
 
Table 4.1 Loci, amplicon length and primers used for PCR. 
Locus Chr Foward Primer  Reverse Primer  Box 1c Box 2c 
Amplicon 
length (bp) 
Pk 1 VI FI 5' TCA TCG CTG AAT CTC ATT GC 3' RI 5' CGC AAA GGG AGA CAA TCA GT 3' NA NA 
 
873 
Gra 6 X FI 5' TTT CCG AGC AGG TGA CCT 3' RE 5' TCG CCG AAG AGT TGA CAT AG 3' NA NA 
 
314 
Sag2 5' VIII F4E 5' GCTACCTCGAACAGGAACAC 3' R4E 5' GCATCAACAGTCTTCGTTGC 3' NA NA 
 
305 
Sag2 3' VIII F3E 5' TCTGTTCTCCGAAGTGACTCC 3' R3E 5' TCAAAGCGTGCATTATCGC 3' NA NA 
 
297 
Sag 3 XII FI 5' TCT TGT CGG GTG TTC ACT CA 3' RI 5' CAC AAG GAG ACC GAG AAG GA 3' NA NA 
 
211 
M 102 VIIa F 5' GAG CGA CGC CCG TAT GAT AAG G 3' R 5' CGC GCT GAG AAG CTG ACA TAC AG 3' NA NA 
 
427 
CB21-4 III F 5' CCA GGT GTT TCG ATA TTG AT 3' R 5' GCC TGT GTG GTG TTC GAA TC 3' TACGCATACA GTACATTCTT 
 
469 
TgM-A X Fa 5' GGCGTCGACATGAGTTTCTC 3'  Rb 5' TGGGCATGTAAATGTAGAGATG 3' CGTGTTTCCA TTTGTAAGTC 
 
207 
B18 VIIa Fa 5' TGGTCTTCACCCTTTCATCC 3' Rb 5' AGGGATAAGTTTCTTCACAACGA 3' TGCCTGTAGC GGATTCCGCA 
 
160 
W35 II Fa 5' GGTTCACTGGATCTTCTCCAA 3' Rb 5' AATGAACGTCGCTTGTTTCC 3' TCTTGGCTTT GTGTCGCTGT 
 
248 
 
 
 
 
Bioinformatics analyses 
For Single Nucleotide Polymorphisms (SNPs) / indel screening, NGS data was processed 
using the mapping-based bioinformatics pipeline implemented in INSaFLU 
(https://insaflu.insa.pt/), which is a web-based platform for amplicon-based NGS data analysis 
(Borges et al., 2018). Briefly, the core bioinformatics steps  involved: i) raw NGS reads quality 
analysis and improvement using FastQC v. 0.11.5; 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc) and Trimmomatic v. 0.27 
(http://www.usadellab.org/cms/index.php?page=trimmomatic), respectively; and, ii) reference-
based mapping, consensus generation and variant detection using the multisoftware tool Snippy 
v. 3.2-dev (https://github.com/tseemann/snippy), using a multi-FASTA file with representative 
sequences of RH strain of each one of the targets amplicons as reference sequence. Mapping 
results were inspected and confirmed through visual inspection using the Integrative Genomics 
Viewer (http://www.broadinstitute.org/igv).  
For in silico microsatellite-size analysis, we took advantage of a previously applied 
bioinformatics script (Pinto et al., 2016) that allows capturing, directly from NGS reads (after 
quality improvement with Trimmomatic), the repeat number profile within the microsatellite 
region (i.e., the microsatellite size). This strategy consists on the extraction and counting DNA 
a
 Primers with adapters  - TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG
c
Sequences contiguously flanking each side of the tandem repeat region that are used for in silico extraction of the microsatellite size. 
NA - not applicable
b
Primers with adapters - GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG
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sequences (i.e., the microsatellites sequences) that are flanked by two conserved, small DNA 
strings. The defined strings for the microsatellite-containing loci are detailed in Table 4.1. 
All raw sequence reads generated in the present study were deposited in the European 
Nucleotide Archive (ENA) (BioProject PRJEB34235). Detailed ENA accession numbers are 
described in Supplementary Table S1. 
4.4. Results 
Throughout the entire 10-month study, in experiment A, we observed that RH strain always 
killed the mice in two days and presented tachyzoites-rich ascites, with a median of 7.50 x 107 / 
ml (mean of 9.15 x 107 / ml SD 4.30 x 107 / ml) tachyzoites recovered in the harvest procedure 
(Figure 4.2). During these two days, the animal showed great prostration, completely bristly hair 
and soft stools (Figure 4.3). In the necropsy of the more than 200 mice enrolled in experiment A, 
no T. gondii cysts were observed in mice brain tissues. 
Figure 4.2 Experiment A: Continuous RH strain mice propagation. The squares represent the tachyzoites 
concentration harvested during the 10-month study period. 
 
 
Figure 4.3 Phenotypic evaluation on the course of experiment A. Panel A shows the phenotypic effect 
of RH strain propagation in mice, where mice can be observed totally prostrate in a corner of the cage 
and with bristly hair; Panel B represents the phenotypic effect of RH strain propagation in HFF, showing 
tachyzoites with a thin shape and motile rich ascites  (40x magnification). 
Image source: National Reference Laboratory of Parasitic and Fungal Infections. 
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Regarding experiment B, we observed an increase in the number of RH strain tachyzoites 
inside the cells within 6 to 9 h, and after approximately 24 h parasites formed rosettes with the 
apical ends directed towards the parasitophorous vacuole membrane and some of them were 
dispersed in the cytoplasm of the host cell. After 72 h, most of the cells were infected and some 
of them detached from the flask. After 96 h, the monolayer was destroyed and a large number of 
tachyzoites could be observed in the supernatant. These observations stood for the entire study 
period. (Figure 4.4) 
 
 
Figure 4.4 Phenotypic evaluation on the course of experiment B. Phenotypic effect of RH strain 
inoculation in HFF (40x magnification). Panel A - HFF monolayer; Panel B - Tachyzoites replicated in 
the cells within 6 to 9 h; Panel C - Tachyzoites formed rosettes with the apical ends directed towards 
parasitophorous vacuole membrane within 24 h; Panel D - Most of HFF are infected and some of them 
detached from the flask within 72 h and Panel E - Monolayer is destroyed and a large number of 
tachyzoites are in the supernatant within 96 h.  
Image source: National Reference Laboratory of Parasitic and Fungal Infections. 
 
We also observed that, in each cycle of three passages (approx. 12 days), the amount of 
tachyzoites that were harvested in each passage progressively decreased, from a median of  
3.36 x 107 / ml (3.58 x 107 / ml SD 7.16 x 106 / ml) in the first passage of each cycle, to a median 
of 1.05 x 107 /ml (mean of 1.08 x 107 / ml SD 1.28 x 106 / ml) in the last passage (Figure 4.5). 
Therefore, in order to avoid losing the strain, the aliquot of the immediate previous passage (i.e., 
second passage) was thawed and used for the subsequent inoculation. This yielded a highly 
homogeneous fluctuation dynamic of the tachyzoites recovery during the entire experiment B 
period (Figure 4.1) Also, within each of these three-passages cycles, the size of the tachyzoites 
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diminished and their shape became rounded, although these phenotypes were hardly seen after 
the first of the three passages.  
Figure 4.5 Experiment B: Continuous RH strain cell line propagation. The circles represent the tachyzoites 
concentrations that were harvested during the study period (60 passages of 72 - 96 h). The different colours 
represent the three passages within each cycle of ~12 days. 
 
We observed that the virulence of the RH strain after long periods of passages in the cell 
line strongly decreased. In fact, after different periods of long passaging in HFF (namely, after 3, 
22 and 44 weeks from the first inoculation), the two mice that were inoculated with the harvested 
tachyzoites did not die in short periods of time. In fact, one of them was euthanized for observation 
after seven days and the other lived for 11 months. The ones that were euthanized showed no 
tachyzoites in the ascitic liquid.  
Finally, regarding experiment C, during the entire 10 - month period, we observed a 
microscopic-based phenotypic profile of tachyzoites that was similar to the one described above 
for the first passage within each cycle of three passages of experiment B (i.e., timelines, rosettes 
formation and tachyzoites shape), i.e., with only sporadic and modest alterations when compared 
with the ones observed in the tachyzoites from the mice ascites.. We observed quite homogeneous 
values of the tachyzoites concentration that were harvested from the mice (median 7.05 x 107, 
mean of 7.03 x 107 / ml SD 8.43 x 106), which were in the same range as in experiment A. For the 
harvested tachyzoites from the cell line, the values obtained (median 2.60 x 107 / ml, mean of 2.35 
x 107 / ml SD 5.50 x 106 / ml) fitted the interval observed for the three passages within each 12-
day cycle of experiment B (Figure 4.6). For better visualization purposes, Figure 4.7 shows the 
comparison of tachyzoites yield between the three propagation experiments. 
We observed that, after each period of 72-96 h in the HFF cell line, the tachyzoites showed 
a virulence decreased phenotype in mice as they caused mice death only after about seven days. 
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Curiously, we observed no obvious decrease in the number of tachyzoites (Fig. 4.6 and 4.7) that 
were recovered in the ascites, when compared with experiment A. 
Figure 4.6: Experiment C: intercalate passages of the RH strain in the cell line and in mice. The circles and 
squares represent the tachyzoites concentration that were harvested from the cell line and mice, respectively, 
during the study period (44 weeks). 
Figure 4.7 Comparison of tachyzoites yield between propagation experiments. This dispersion graph 
displays the concentration of T. gondii (expressed as tachyzoites/ml) that were harvested during the 
three parallel propagation experiments: For experiments A and C, each value reflects the tachyzoites 
concentration that was harvested each week (a total of 44 weeks), while, for experiment B, each value 
reflects the tachyzoites concentration obtained after each passage (a total of 60 passages). For 
experiment B, it also shows the yield obtained after the first (red circles), second (blue circles), and third 
passage (green circles) within each cycle of three passages (~12 days). Circles and squares represent 
concentration values obtained from harvested cells and mice, respectively.  
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Finally, regarding the evaluation of potential genomic changes arising throughout 
propagation, which enrolled ten samples (about one per month) from each “experiment” and 
targeted nine genome loci, we observed no SNP/indels both chronologically (for a given 
experiment) and between experiments. Also, for microsatellite-harbouring loci (B18, W35, TgM 
A and CB21-4), we observed the same consensus microsatellite length (and profile) for all 
samples. Of note, the consensus lengths retrieved by our NGS/Bioinformatics-based approach for 
the RH strain matched the ones previously reported (Vilares et al., 2017) by traditional 
microsatellites-based analyses relying on electrophoresis-based DNA sizing. 
 
4.5. Discussion 
The maintenance of reference strains, namely the RH, in a National Reference Laboratory 
(NRL) is imperative since the Sabin- Feldedman dye test is the Gold Standard among serological 
test and requires fresh viable tachyzoites. While parasite propagation is obligatory for antigen 
production, it is also useful for tachyzoites enrichment for typing purposes, and can also provide 
vital information in studies focusing T. gondii lifecycle (and its particular stages) (Lambert et al., 
2006; Lachenmaier et al., 2014), host invasion and host–parasite interactions. Although some of 
these goals may be achieved by using cell-lines for tachyzoites’ propagation, such as antigen 
production (Evans R., 1999), the animal model remains crucial for studying the natural infection 
dynamics and parasite dissemination, and is required to confirm findings after initial in vitro 
investigations (Szabo and Finney, 2017). Also, the in vivo model has a vital role in a NRL because 
it is the gold standard method for the isolation of T. gondii strains in biological samples or body 
fluids (Derouin et al., 1987) constituting, for instance, the reference methodology in pre- and post-
natal diagnosis of toxoplasmosis. However, this in vivo procedure frequently involves the need to 
sacrifice hundreds of mice per year, and is also extremely laborious, requiring complex facilities 
and human skills either for the isolation of strains or for their maintenance process. Furthermore, 
the legislative regulations and the ethical measures that have been arising regarding the use of 
animals in the laboratory (EEC, 1986; Haywood and Carbone, 2009; 2010/63/EU, 2010) push the 
researchers towards the use of alternative approaches to diminish the animal manipulation. As 
such, recent technological advances rely, for instance, in the development of three-dimensional 
(3D) tissue culture models as well as on engineering specific tissues and organs for laboratory 
use. These improved models try to mimic in vivo host physiology and could replace current in 
vivo models, thus reducing the need for animal manipulation. For example, in the field of 
congenital toxoplasmosis, a recent study enrolling the development of a 3D culture system based 
on trophoblasts allowed to investigate the interaction between specialized cells of the embryonic 
epithelial that are in direct contact with maternal blood (syncytiotrophoblasts) (McConkey et al., 
2016) and T. gondii. However, in general, these developed models are in an embryonic stage and 
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still constitute a long shot for routine use in most laboratories. As such, on behalf of our role as 
the reference laboratory for toxoplasmosis at the Portuguese National Institute of Health, we 
aimed to investigate if we can replace, or at least reduce, the demanding animal model for strain 
propagation by using “feasible” methodologies. Therefore, we used three parallel approaches 
consisting of continuous passages of the RH strain in mice (Experiment A), in a cell line 
(Experiment B), and intercalate passages of the RH strain in the cell line and in mice (Experiment 
C).  
In order to compare the outcomes of each propagation experiment, we started to evaluate 
the tachyzoites capacity to maintain an active multiplication in a cell line throughout continuous 
passaging. As expected, throughout continuous propagation in mice (Experiment A) we always 
obtained tachyzoites-rich ascites with values for tachyzoites contentration in the harvesting 
processes (median of 7.50 x 107 / ml) that were up to 7.5 - fold higher than the ones obtained for 
the approach enrolling the exclusive propagation in the cell line. (Experiment B). Curiously, in 
Experiment C, which enrolled 46 passages in the cell line intercalated with 14 passages in mice, 
we faced a very encouraging scenario. In fact, not only we obtained tachyzoite-rich ascites with 
harvesting values (median of 7.05 x 107 / ml), similar to the ones obtained in Experiment A, but 
we also obtained tachyzoites yields in the multiples harvesting processes of the cell line (median 
of 7.05 x 107 / ml) about 2.5 - fold higher than the ones obtained at the end of each cycle in 
Experiment B (Figures 4.6 and 4.7). This suggests that, although the tachyzoites capacity to 
maintain an active multiplication in a cell line throughout continuous passaging decreases over 
time (we observed a ~3-fold decrease from the first to the third passage within each cycle of ~12 
days in Experiment B) (Figure 4.5), this capacity seems to be renewed when, after short periods 
in a cell line (e.g., one week, Experiment C), the tachyzoites are transferred to mice. 
A second evaluation consisted of assessing potential phenotypic alterations upon 
propagation of the parasite in a cell line, such as tachyzoites shape and motility. Contrasting to 
Experiment A for which we observed tachyzoite-rich ascites with tapered shape and with motility, 
the continuous propagation of tachyzoites in the cell line lead to a decrease in their size and to an 
alteration of its shape, which was notably seen at the end of each 12-days cycle. This was 
consistently observed for all 12 - days cycles of Experiment B. Noteworthy, minor phenotypic 
changes were observed in the microscopic observation of tachyzoites harvested from the cell line 
in Experiment C, whereas a typical phenotype could be seen in the mice ascites.  
Afterwards we evaluated the capacity to maintain a virulence phenotype in mice. Regarding 
Experiment A we observed that RH strain always killed the mice in two days, as is routinely 
observed in our laboratory for this strain. This is concordant with what is expected for T. gondii 
genotype I strains, which are usually responsible for lethal infections in mice, while types II and 
 Chapter IV 
Parallel propagation of  Toxoplasma gondii in vivo, in vitro  and alternate models: towards less dependence on the mice model  
 
 
71 
 
III are significantly less virulent (Lambert et al., 2006). Several studies showed (Saeij et al., 
2005b; Kim et al., 2007) that a prolonged passage in mice of Type I RH strain leads to an 
attenuation of tissue cysts/bradyzoites formation, although this assumption is not consensual. 
There are still controversies on the potential of cyst formation of this strain but, similarly to 
several studies, (Asgari et al., 2013) we observed that our RH strain lost its ability of cystogenesis 
possible due to the prolonged and interrupt mice passages since 1985. In particular for Experiment 
B, we also evaluated the impact of the tachyzoites long-term passaging in the HFF cell line at 
three time points (at week 3, 22 and 44) after the first inoculation, and observed that the RH strain 
completely lost its virulence. In fact, when we inoculated the harvested parasite into two mice and 
euthanized one of them (the other died of old age) for observation, there were neither tachyzoites 
in its ascite nor cysts in the brain. In Experiment C, we observed an intermediate scenario, as 
some virulence decreased phenotype in mice was observed after ~1 week in cell culture 
(throughout the entire study period) because RH strain consistently killed the mice after about 
seven days and not in two days as in Experiment A. This strongly suggests that, although a 
continuous passaging in cell lines may be useful for some specific proposes (e.g., antigen 
production), this approach cannot be successfully used for maintaining T. gondii strains for other 
reference purposes as they unequivocally loose the virulence phenotype. Nevertheless, hybrid 
approaches such as the here presented in Experiment C seem to have the potential to overcome 
the virulence issue, which is crucial in most T. gondii reference laboratories. 
Finally in order to assess if the propagated RH strain underwent genomic changes 
throughout propagation (regardless the strategy), we conducted a humble genomic evaluation 
focused on both traditional typing loci and selected polymorphic loci that are genome-dispersed 
and are believed to play a role in adaptation. Whereas the hypothetical detection of genetic 
alterations throughout the study could suggest the putative inadequacy of using the selected 
approaches for strain maintenance, we observed no genetic changes throughout each experiment 
and between experiments. Thus, contrarily to the former hypothesis, no definitive conclusions 
about genetic stability can be taken, given the limited extent of the T. gondii genomic regions that 
were surveyed Nevertheless, broader evaluations at the genomic level are very challenging, 
considering both the large genome size (~65 Mb) and the high complexity of the 14 chromosomes 
of T. gondii . Genome-wide surveys would make this evaluation impractical and cost prohibitive. 
Of note, in this study, we unprecedentedly applied a robust NGS/bioinformatics approach for in 
silico extraction of the microsatellite size for three loci (TgM-A, B18, W35) traditionally used in 
microsatellites-based T. gondii genotyping. This technological innovation constitutes a proof-of-
concept that the traditional microsatellites analyses (based on laborious and error-prone 
electrophoresis-based DNA sizing) might be straightforwardly transfer to more robust 
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NGS/bioinformatics-based methodologies, while keeping backwards compatibility with 
“historical” typing data.  
As concluding remarks, the results of the present study demonstrate the feasibility of using 
tachyzoites propagation approaches based on alternate passages on mice and cell lines, strongly 
impacting the number of sacrificed mice. This would enable laboratories to maintain and 
propagate T. gondii strains and use them for virtually any purpose, as not only the replication 
capacity, shape and motility of tachyzoites seems to be maintained, but also the virulence appears 
not to be obliterated. Finally, although a humble genomic survey was performed, no apparent 
genetic alterations were observed as a consequence of in vitro propagation. Nevertheless, other 
evaluations will be needed, eventually enrolling other cell lines, propagation time lines and strains 
other than the reference strain RH (that is maintained in all reference labs) in order to reach more 
definite conclusions regarding the usefulness of T. gondii propagation approaches as the one 
presented here. 
 
 
  
 73 
 
 
 
 
 
 
 
 Chapter V 
Final overview, concluding remarks and future perspectives  
  
 74 
 Chapter V 
Final overview, concluding remarks and future perspectives  
 
 
75 
 
5. Final overview, concluding remarks and future perspectives  
T. gondii is one of the most successful parasitic organismsis that infects over a third of the 
world's humanity. Humans remain infected for their whole lives and this infection constitutes a 
life-long threat. The high disease burden reported in the multiple studies performed worldwide 
(referred in chapter I of this dissertation) highlights the lifetime effects that T. gondii can have on 
infected individuals and the worldwide public health concern that this infection represents. The 
main goal of this PhD thesis was to contribute for the knowledge of toxoplasmosis in Portugal. 
We pursued this goal essentially due to the existence of significant knowledge gaps regarding 
toxoplasmosis in our country. Firstly, Portuguese national health authorities considered that there 
was a lack of knowledge on the epidemiological situation of toxoplasmosis in Portugal, even 
though congenital toxoplasmosis is a mandatory notifiable disease in our country. Secondly, there 
was also a lack of data regarding the T. gondii circulating genotypes in humans and this issue 
gains special relevance since our country  has a long history of trade and social interaction with 
our ex colonies, involving human and animal migrations and also import/export of food products. 
Finally, on behalf of the animal welfare by imposition of legislative regulations introduced in the 
last years in Europe, we also developed laboratory approaches aiming at replacing, or at least 
reducing, the laboratory animal manipulation that is a daily requirement in a toxoplasmosis 
reference laboratory. 
In chapter II, we focused our efforts in evaluating the T. gondii seroprevalence in the 
Portuguese population by a comparison of three cross-sectional studies spanning three decades 
(1979 / 80, 2001 - 2002 and 2013). We assessed the seroprevalence trends in the Portuguese 
general population, by age group, region and gender with special focus on women of childbearing 
age. We analysed the presence of T. gondii IgG specific antibodies in 1657 sera from the 2001 - 
2002 survey and in 1440 sera from the 2013 survey, by using the automated methodology Enzyme 
Linked Fluorescent Assay for screening purposes and the Direct Agglutination Test to clarify the 
equivocal samples. Concerning the 1979/80 survey we didn’t perform laboratorial work because 
the data was already available. The T. gondii overall seroprevalence decreased from 47% in 
1979/1980 to 22 % in the 2013 survey, and concerning childbearing women we observed a 
decrease from 53 % in 1979 – 1980 to 18 % in 2013. We also observed that the prevalence of T. 
gondii IgG increased significantly with age, indicating that infection is acquired throughout life. 
The observation that T. gondii seroprevalence decreased over time, both in the general population 
and in the childbearing women, is in agreement with what was observed in many developed 
countries where T. gondii seroprevalence declined sharply over the past three decades 
(Nowakowska et al., 2006c). Of special relevance is the scenario obtained for childbearing 
women, indicating that about 80 % of Portuguese women are not immune against the T. gondii
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infection, and that the majority of potential pregnant women are susceptible to primary infection 
yielding a risk of congenital toxoplasmosis and respective sequel. Thus, the low prevalence 
observed among women of childbearing age should not be neglected. The incidence of infection 
is dependent on the general seroprevalence, determining the population susceptibility and the 
frequency of risk factors for toxoplasmosis acquisition. Therefore, seroprevalence should be 
considered a strong indicator to establish screening policies. This study reinforces that prenatal 
screening for toxoplasmosis is necessary due to the high rate of seronegative women exposed to 
infection and the consequent probability of a high number of primary infections in the 
childbearing period. Since there is no vaccine to prevent human toxoplasmosis, the improvement 
of primary prevention constitutes a major tool to avoid infection in the susceptible groups. We 
believe that the evaluation of seroprevalence of toxoplasmosis in Portuguese population was of 
great significance in public health because it allowed us to infer the risk of infection, namely of 
pregnant women and of women in childbearing age, allowing health authorities to perform an 
effective prevention for this life threat infection. Of note, this study would have been enriched if 
we had the opportunity to evaluate other risk factors of infection. However, this could not be 
performed due to the lack of more complete personal, socioeconomic and demographic 
information. To overcome this limitation and also in the context of epidemiological studies, we 
intend to give a step forward and identify the sources of T. gondii infection. We will discuss this 
issue afterwards in the future perspectives item. 
We then extended the focus of the study to the parasite, thus, on behalf of national reference 
laboratory mission, in chapter III we intended to genetically characterize the T. gondii strains 
isolated from the several biological samples from the population with suspected toxoplasmosis  
that attended to the NIH to perform the laboratorial diagnosis of T. gondii. We also studied the 
demographic characteristics of the referred patients and estimated the rate of new cases in the last 
10 years. The complete pre and postnatal diagnosis of congenital toxoplasmosis is composed by 
serological, molecular and mice inoculation approaches and this laboratory work are carried out 
in Portugal exclusively at NIH. Considering this, it is reasonable to assume that the existing 
collection of biological products and strains likely constitutes a national representation of this 
infection. A total of 5722 cases were analysed, being 1459 (25.5 %) cases confirmed as 
toxoplasmosis, 98.4 %, (1436 cases) of these were new cases of acquired toxoplasmosis and 1.6 
%, (23 cases) were new cases of congenital toxoplasmosis. With the exception of France, 
Germany and Poland that showed the highest rates of congenital toxoplasmosis in Europe, the 
number of new cases per year found in this study was similar to the ones observed in the other 
European countries (ECDC, 2013, 2015, 2017). This is somehow in line with the prevalence 
estimated in the Chapter II for the general Portuguese population in 2013 (22 %), which 
constitutes a low value when compared with the ones obtained in France, Germany and Poland 
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and some other countries from the north of Europe (Pappas et al., 2009). The policies of active 
screening of pregnant women in these countries, especially in France, can explain why these 
countries report the highest rates of congenital toxoplasmosis among reporting EU/EEA countries 
(ECDC, 2017). Concerning T. gondii genetic characterization, we analyzed 48 strains isolated in 
a congenital and acquired toxoplasmosis context from the biological samples of the referred 
positive cases. Similar  to other European studies (Nowakowska et al., 2006b; Ajzenberg et al., 
2015) we found a majority of type II strains (73 %; 35/48) using Sag2 classical PCR methodology. 
Curiously, we found 21 % (10/48) of recombinant strains by PCR of five microsatellites, although 
these strains had previously been identified as type II or I by Sag2 classical genotyping. This 
suggests that multi-loci approaches for typing purposes that may be developed in a near future 
may soon reveal a considerably higher recombination scenario in T. gondii than the one that is 
currently assumed. Regarding the virulence phenotype, we observed a virulence rate of 15 % 
(7/48) in mice inoculation, which was quite low but was similar to the one observed in other 
countries (Ajzenberg et al., 2002b; Gebremedhin et al., 2014b). An unexpected finding was that 
only three type I strains demonstrated virulence in mice, and, on the contrary, one type II strain 
killed the mice in 120 days after the first inoculation (and continued killing mice in less time in 
the subsequent passages). A possible explanation for this fact is that some of the strains classified 
as type I and II by classical Sag2 and 5 microsatellites may not be “true” type I and II but instead 
recombinant strains. The recombinant strains may be of great relevance, as it is believed that they 
are associated with more severe symptoms in immunocompetent and immunocompromised hosts 
and could pass through the placenta more easily than the archetypal strains (Grigg et al., 2001b). 
Nevertheless, revealing a recombinant character by simply using the traditional typing loci is 
certainly a too humble approach as the probability of finding recombinant strains increases if 
broader genomic regions are evaluated. Therefore it is imperative to better characterize the genetic 
background of these unusual strains as unusual genotype-phenotype associations (e.g., 
implications in specific disease outcomes) may eventually be found for some recombinant 
profiles. In this regard, it will be important to analyze several other loci that are polymorphic and 
genome dispersed, in order to better understand the degree of genomic mosaicism displayed by 
the circulating strains. Overall, this study presents the first data in Portugal concerning T. gondii 
genotyping from human samples and it reveals genetic variations in the predominant clonal 
lineages and more specifically the existence of a considerable proportion of recombinant strains. 
The tasks enrolled in this previous study, which are strongly associated with the role of the 
laboratory at the Portuguese NIH as the national reference laboratory, deeply involve the use of 
the animal model, not only to propagate the prototype T. gondii strains (e.g. RH strain) and the 
clinical isolates, but also to enrich the parasitic load of the biological samples to increase the 
success of the typing procedures. Thus, in Chapter IV we aimed to give a step forward towards 
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the improvement of good practices regarding the use of the animal model in our reference 
laboratory. To reach this goal, we evaluated the genetic and phenotypic stability of the virulent  
T. gondii RH strain throughout its parallel propagation in mice, in a cell line, and in an alternating 
way of these two procedures. To fulfill this objective we performed three parallel approaches 
during a period of 10 months, namely, a continuous passage of the RH strain in mice (Experiment 
A), a continuous passage of the RH strain in human foreskin fibroblasts (Experiment B) and the 
use of intercalate passages of the RH strain in the cell line and in mice (Experiment C). We then 
evaluated multiple phenotypic aspects, such as the capacity to maintain an active multiplication, 
the tachyzoites shape, number, motility, the capacity to maintain a virulence phenotype in mice, 
and also evaluated potential genotypic alterations throughout cell line versus mice propagation.  
One of the highlights of this study is our finding in Experiment C, namely, the observation of 
tachyzoite-rich ascites with harvesting values similar to the ones obtained in Experiment A. To 
reinforce the success of this experiment we also obtained tachyzoites yields in the multiples 
harvesting processes of the cell line about 2.5 - fold higher than the ones obtained at the end of 
each cycle in Experiment B. This outcome indicates that while the ability of tachyzoites to 
maintain active multiplication in a cell line during continuous passage decreases over time, this 
ability appears to be renewed when, after short periods in a cell line (eg, a week, experiment C), 
tachyzoites are transferred to mice. We also assessed the impact of long-term tachyzoite passage 
in the HFF cell line at three time points (at weeks 3, 22, and 44) after the first inoculation 
(Experiment B) and observed that the RH strain completely lost its virulence. We observed no 
tachyzoites in the ascites and no cysts in the brain after scarification of the mice inoculated with 
the parasite that was harvested from the referred three time points. Also, the other mouse that was 
inoculated with the same harvested parasite died of old age. These data strongly suggest that a 
long-term passaging of the parasite exclusively in a cell line is highly detrimental in terms of 
tachyzoites virulence. Concerning the evaluation of potential genomic changes throughout 
propagation, which enrolled ten samples (about one per month) from each “experiment” and 
targeted nine genome loci, we observed no SNP/indels both chronologically (for a given 
experiment) and between experiments, thus no apparent genetic alterations were observed as a 
consequence of in vitro propagation. Nevertheless, it should be emphasized that, although we 
surveyed loci that are polymorphic and believed to be involved in adaptation (de Melo Ferreira et 
al., 2006; Ajzenberg et al., 2010; Su et al., 2010), they represent just a tiny part of the large  
T. gondii genome, hampering strong conclusions about this specific evaluation.  
Since the publication of The Principles of Humane Experimental Technique,by Russell and 
Burch in 1959 (Russell and Burch, 1959), scientists and government agencies all over the world 
have endorsed replacement, reduction, and refinement as essential tools for promoting the humane 
treatment of research animals. In the Principles, Russell and Burch proposed a new applied 
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science that would improve the treatment of laboratory animals while advancing the quality of 
science in studies that use animal manipulation. They introduced the definitions of the 3Rs 
(“replacement, reduction, and refinement”), which subsequently have become known as 
‘alternative methods’ for minimizing the potential for animal pain and distress in biomedical 
research. It should be noted that it was not the use of animals in research that these scientist found 
problematic, but the infliction on research animals of unnecessary or avoidable pain, fear, stress, 
anxiety, bodily discomfort and other significantly unpleasant feelings (Tannenbaum and Bennett, 
2015) They defended the principle that, when it is scientifically appropriate to use animals in 
research or testing, all reasonable efforts should be made to minimize and, when possible, 
eliminate the stress experienced by these animals. At the NRL of the Portuguese NIH we can't 
abandon the animal model because it constitutes both the serological and isolation reference 
method for diagnosis of congenital and acquired toxoplasmosis, playing also irreplaceable roles 
in studies focusing natural infection dynamics and parasite dissemination. Nevertheless, our data 
suggests that we can significantly reduce the use of the demanding in vivo model and we will now 
adopt the Experiment C procedure for RH strain propagation in our laboratory. This would 
strongly impact, not only the number of sacrificed mice in our routine procedure, (about 360 
animals per year that we can reduce to about 70) but would also ensure the putative maintenance 
of the virulence of the passaged strain. 
As concluding remarks, we believe that this PhD dissertation contributes to the better 
knowledge of toxoplasmosis in Portugal in an epidemiological, genetic and animal 
experimentation manner. In fact, not only we used a human-targeted approach and determined the 
T. gondii seroprevalence throughout the last decades, but we also focused on the parasite by 
assessing the genetic variability of the disease-causing clones and their virulence in mice, and 
finally established procedures aiming at reducing the number of sacrificed animals that are 
routinely used for both diagnostic and research purposes. 
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Future perspectives: 
The future perspectives are drawn according to the results of this PhD dissertation and the 
laboratory's ability. Thus, we anticipate three major tasks to be developed in a near future: 
To overcome the lack of the identification of the risk factors of infection in the study 
described in Chapter II we intend to go a step forward and identify the sources of T. gondii 
infection. Eating undercooked meat is currently considered a major source of T. gondii infections 
in Europe, moreover, and as we have already observed, there are major geographical differences 
in the epidemiology of the parasite as well as in consumption habits, which affects the importance 
of different transmission routes and specific product types. In 2011 the identification of a 
sporozoite specific antigen (TgERP) enabled researchers to detect infections caused through 
oocysts by a serological method (Dolores Hill, Cathleen Coss, 2011) but identification through 
cysts is still missing. To accomplish this propose we aim to develop a novel NGS-MLST typing 
method that can detect within-genotype patterns that are important for understanding transmission 
routes and source tracing, and may improve preparedness to identify outbreaks and imported 
emerging atypical strains. The lack of information on the attribution to specific infection sources 
has hampered the development of effective intervention strategies and science-to-policy 
translation. 
On behalf of the data presented in chapter III, we will proceed with studies that are already 
ongoing in our laboratory towards the implementation of a multi loci NGS-based approach to 
perform a more robust genetic characterization of the T. gondii isolates. This will also allow us to 
better identify recombinant strains, which are believed to have specific phenotypic properties and 
likely geographical distribution. Ultimately, this may also be useful for future genotype-
phenotype association studies, which may reveal genomic structures potentially associated with 
an increased virulence phenotype and specific disease outcomes, launching basis for the 
development of proper prophylactic or therapeutic measures.  
Regarding the outputs of chapter IV, we aim to understand if the approach of Experiment 
C is also successfully adaptable to the collection of clinical strains in the Reference laboratory, 
and not only to the highly virulent RH strain that was enrolled in the pilot study. This would 
tremendously impact the routine laboratory procedures associated with the maintenance of the 
viable T. gondii strains, namely with the significative reduction of the sacrificed mice.  
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Supplementary Table S 4.1 BioProject PRJEB34235 
European Nucleotide Archive (ENA) accession numbers. 
SAMPLE ID 
ENA 
BioProject 
READS ENA 
ACCESSION 
Tg_RH_1_A PRJEB34235 ERR3505173 
Tg_RH_2_A PRJEB34235 ERR3505211 
Tg_RH_3_A PRJEB34235 ERR3505219 
Tg_RH_4_A PRJEB34235 ERR3505218 
Tg_RH_5_A PRJEB34235 ERR3505214 
Tg_RH_6_A PRJEB34235 ERR3505175 
Tg_RH_7_A PRJEB34235 ERR3505196 
Tg_RH_8_A PRJEB34235 ERR3505188 
Tg_RH_9_A PRJEB34235 ERR3505191 
Tg_RH_10_A PRJEB34235 ERR3505210 
Tg_RH_11_A PRJEB34235 ERR3505195 
Tg_RH_12_A PRJEB34235 ERR3505202 
Tg_RH_13_A PRJEB34235 ERR3505183 
Tg_RH_14_A PRJEB34235 ERR3505208 
Tg_RH_15_A PRJEB34235 ERR3505201 
Tg_RH_16_A PRJEB34235 ERR3505162 
Tg_RH_17_A PRJEB34235 ERR3505161 
Tg_RH_18_A PRJEB34235 ERR3505169 
Tg_RH_19_A PRJEB34235 ERR3505213 
Tg_RH_20_A PRJEB34235 ERR3505174 
Tg_RH_21_A PRJEB34235 ERR3505198 
Tg_RH_22_A PRJEB34235 ERR3505160 
Tg_RH_23_A PRJEB34235 ERR3505178 
Tg_RH_24_A PRJEB34235 ERR3505205 
Tg_RH_25_A PRJEB34235 ERR3505204 
Tg_RH_27_A PRJEB34235 ERR3505171 
Tg_RH_28_A PRJEB34235 ERR3505212 
Tg_RH_30_A PRJEB34235 ERR3505203 
Tg_RH_31_A PRJEB34235 ERR3505159 
Tg_RH_32_A PRJEB34235 ERR3505166 
 100 
Tg_RH_1_NA PRJEB34235 ERR3505163 
Tg_RH_2_NA PRJEB34235 ERR3505189 
Tg_RH_3_NA PRJEB34235 ERR3505179 
Tg_RH_4_NA PRJEB34235 ERR3505206 
Tg_RH_5_NA PRJEB34235 ERR3505168 
Tg_RH_6_NA PRJEB34235 ERR3505190 
Tg_RH_7_NA PRJEB34235 ERR3505164 
Tg_RH_8_NA PRJEB34235 ERR3505172 
Tg_RH_9_NA PRJEB34235 ERR3505167 
Tg_RH_10_NA PRJEB34235 ERR3505184 
Tg_RH_11_NA PRJEB34235 ERR3505182 
Tg_RH_12_NA PRJEB34235 ERR3505197 
Tg_RH_13_NA PRJEB34235 ERR3505170 
Tg_RH_14_NA PRJEB34235 ERR3505165 
Tg_RH_15_NA PRJEB34235 ERR3505199 
Tg_RH_16_NA PRJEB34235 ERR3505216 
Tg_RH_17_NA PRJEB34235 ERR3505215 
Tg_RH_18_NA PRJEB34235 ERR3505193 
Tg_RH_19_NA PRJEB34235 ERR3505186 
Tg_RH_20_NA PRJEB34235 ERR3505177 
Tg_RH_21_NA PRJEB34235 ERR3505209 
Tg_RH_22_NA PRJEB34235 ERR3505185 
Tg_RH_23_NA PRJEB34235 ERR3505194 
Tg_RH_24_NA PRJEB34235 ERR3505192 
Tg_RH_25_NA PRJEB34235 ERR3505180 
Tg_RH_26_NA PRJEB34235 ERR3505176 
Tg_RH_27_NA PRJEB34235 ERR3505181 
Tg_RH_28_NA PRJEB34235 ERR3505187 
Tg_RH_30_NA PRJEB34235 ERR3505217 
Tg_RH_31_NA* PRJEB34235 ERR3505200 
Tg_RH_32_NA* PRJEB34235 ERR3505207 
   * RH positive controls  
